Vuzix (VUZI) 10-K 9 Apr 14 2013 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Apr. 09, 2014	Jun. 30, 2013
Document Information [Line Items]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Trading Symbol	'VUZI	'	'
Entity Common Stock, Shares Outstanding	'	10,243,641	'
Entity Registrant Name	'Vuzix Corp	'	'
Entity Central Index Key	'0001463972	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$14,378,000

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current Assets	'	'
Cash and Cash Equivalents	$310,140	$66,554
Accounts Receivable, Net (Note 7)	214,920	170,600
Inventories (Note 8)	953,627	687,181
Deferred Offering Costs (Note 9)	0	199,571
Prepaid Expenses and Other Assets	200,936	85,768
Total Current Assets	1,679,623	1,209,674
Tooling and Equipment, Net (Note 10)	446,329	664,967
Patents and Trademarks, Net (Note 11)	495,608	551,307
Software Development, Net (Note 12)	240,561	0
Total Assets	2,862,121	2,425,948
Current Liabilities	'	'
Accounts Payable	2,420,571	2,896,567
Lines of Credit (Note 13)	0	112,500
Notes Payable (Note 14)	278,467	258,209
Current Portion of Long-term Debt, net of discount (Note 20)	99,320	1,060,188
Current Portion of Capital Leases	24,670	57,244
Customer Deposits (Note 15)	170,777	63,079
Accrued Interest	36,935	161,703
Accrued Expenses (Note 16)	554,264	519,672
Income and Other Taxes Payable	75,851	21,486
Total Current Liabilities	3,660,855	5,150,648
Long-Term Liabilities	'	'
Long Term Derivative Liability (Note 17)	12,035,816	0
Accrued Compensation (Note 18)	0	1,010,096
Long Term Portion of Term Debt, net of discount (Note 19)	170,496	1,715,253
Long Term Portion of Capital Leases (Note 20)	16,882	40,041
Long Term Portion of Accrued Interest	16,365	719,475
Total Long-Term Liabilities	12,239,559	3,484,865
Total Liabilities	15,900,414	8,635,513
Stockholders' Equity (Deficit)	'	'
Preferred Stock — $.001 Par Value, 5,000,000 Shares Authorized; 0 Shares Issued and Outstanding in Each Period	0	0
Common Stock — $.001 Par Value, 700,000,000 Shares Authorized; 9,600,453 Shares Issued and Outstanding December 30, 2013 and 3,536,865 on December 31, 2012	9,600	3,537
Additional Paid-in Capital	23,244,639	19,933,202
Accumulated (Deficit)	-36,292,532	-26,146,304
Total Stockholders’ Equity (Deficit)	-13,038,293	-6,209,565
Total Liabilities and Stockholders’ Deficit	$2,862,121	$2,425,948

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par Value	$0.00	$0.00
Common Stock, Shares Authorized	700,000,000	700,000,000
Common Stock, Shares Issued	9,600,453	3,536,865
Common Stock, Shares Outstanding	9,600,453	3,536,865

CONSOLIDATED_STATEMENTS_OF_CHA

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY (USD $)		Total	Common Stock		Additional Paid-in Capital	Accumulated Deficit	Preferred Stock	Subscription Receivable
Balance at Dec. 31, 2011		($6,824,748)	$3,537		$19,716,963	($26,469,144)	$0	($76,104)
Balance (in shares) at Dec. 31, 2011		'	3,536,865	[1]	'	'	0	'
Forgiveness of Debt		46,037	0		46,037	0	0	0
Stock Compensation Expense		172,233	0		172,233	0	0	0
Forgiveness of Subscriptions Receivable		74,073	'		-2,031	'	'	76,104
Net Income (Loss)		322,840	0		0	322,840	0	0
Balance at Dec. 31, 2012		-6,209,565	3,537		19,933,202	-26,146,304	0	0
Balance (in shares) at Dec. 31, 2012		'	3,536,865	[1]	'	'	0	'
Forgiveness of Debt		0	'		'	'	'	'
Issuance of Common Stock in Public Offering (in shares)	[1]	'	4,025,000		'	'	'	'
Issuance of Common Stock in Public Offering		8,050,000	4,025		8,045,975	'	'	'
Direct Financing Associated Costs		-1,358,641	'		-1,358,641	'	'	'
Conversion of Term Debt and Accrued Interest (in shares)	[1]	'	1,158,003		'	'	'	'
Conversion of Term Debt and Accrued Interest		2,316,007	1,158		2,314,849	'	'	'
Conversion of Accrued Compensation and Interest (in shares)	[1]	'	821,285		'	'	'	'
Conversion of Accrued Compensation and Interest		1,642,569	821		1,641,748	'	'	'
Exercise of Warrants (in shares)	[1]	'	59,300		'	'	'	'
Exercise of Warrants		133,425	59		133,366	'	'	'
Stock Compensation Expense		159,272	0		159,272	0	0	0
Issuance of Warrants in Conjunction with Public Offering		-8,236,786	'		-8,236,786	'	'	'
Reclass Fair Value of Warrant Derivative Liability upon Expiration of Full Ratchet Price Protection		526,245	'		526,245	'	'	'
Reclass Fair Value of Warrant Derivative Liability upon Exercise		85,409	'		85,409	'	'	'
Net Income (Loss)		-10,146,228	0		0	-10,146,228	0	0
Balance at Dec. 31, 2013		($13,038,293)	$9,600		$23,244,639	($36,292,532)	$0	$0
Balance (in shares) at Dec. 31, 2013		'	9,600,453	[1]	'	'	0	'
[1]	All share amounts for all periods reflect the Company’s 1-for-75 reverse stock split, which was effective February 6, 2013.

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012
Sales of Products	$1,856,806		$2,692,152
Sales of Engineering Services	532,247		536,076
Total Sales	2,389,053		3,228,228
Cost of Sales — Products	1,354,909		2,135,484
Cost of Sales — Engineering Services	227,186		205,542
Total Cost of Sales	1,582,095		2,341,026
Gross Profit	806,958		887,202
Operating Expenses:	'		'
Research and Development	1,751,397		1,153,403
Selling and Marketing	1,091,514		1,225,154
General and Administrative	2,165,341		2,181,310
Depreciation and Amortization	377,840		468,817
Impairment of Patents and Trademarks	73,423		64,703
Total Operating Expenses	5,459,515		5,093,387
(Loss) from Continuing Operations	-4,652,557		-4,206,185
Other Income (Expense)	'		'
Interest and Other (Expense) Income	0		232
Other Taxes	-88,274		-20,398
Foreign Exchange Gain (Loss)	-13,692		-11,111
(Loss) on Sale of Assets	-40,352		0
(Loss) on Debt Extinguishment (Note 19)	-1,272,296		0
Gain (Loss) on Derivative Valuation (Note 17)	-3,575,278		0
Interest Expense	-503,779		-509,925
Total Other Income (Expense)	-5,493,671		-541,202
(Loss) from Continuing Operations Before Provision for Income Taxes	-10,146,228		-4,747,387
Provision (Benefit) for Income Taxes (Note 21)	0		0
(Loss) from Continuing Operations	-10,146,228		-4,747,387
Income (Loss) from Discontinued Operations (Note 4)	0		-747,580
Gain on Disposal of Discontinued Operations (Note 5), net of tax	0		5,817,807
Net Income (Loss)	($10,146,228)		$322,840
Earnings (Loss) per Share from Continuing Operations (Note 6)	'		'
Basic	($1.69)		($1.34)
Diluted	($1.69)	[1],[2]	($1.34)	[1],[2]
Earnings (Loss) per Share	'		'
Basic	($1.69)		$0.09
Diluted	($1.69)	[1]	$0.09	[1]
Weighted-average Shares Outstanding	'		'
Basic	5,988,595		3,536,865
Diluted	5,988,595		3,651,100
[1]	Due to net loss for period, dilutive loss per share is the same as basic.
[2]	Due to the antidilutive impact of the convertible debt under the if-converted method, the diluted earnings per share is the same as basic.

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows from Operating Activities	'	'
Net Income (Loss)	($10,146,228)	$322,840
Non-Cash Adjustments	'	'
Depreciation and Amortization	377,840	468,817
Impairment of Patents and Trademarks	73,423	64,703
Stock-Based Compensation Expense	159,272	172,233
Loss on Sale of Assets	40,352	0
Interest Converted into Common Stock	222,032	0
Amortization of Term Debt Discount	25,302	777,550
Amortization and Write-off of Term Debt Discount	732,584	0
Amortization and Write-off of Debt Issuance Costs	257,692	0
Warrants Issued for Debt Extinguishment	97,913	0
Loss on Derivative Liability Valuation	3,575,278	0
Gain on Sale of Discontinued Operations	0	-5,817,807
Forgiveness of Debt	0	46,037
Non Cash Compensation	'	74,073
(Increase) Decrease in Operating Assets	'	'
Accounts Receivable	-44,320	607,885
Inventories	-266,446	717,499
Prepaid Expenses and Other Assets	-37,993	14,857
Increase (Decrease) in Operating Liabilities	'	'
Accounts Payable	-379,634	-912,122
Accrued Expenses	34,592	99,832
Customer Deposits	107,698	-329,073
Income Taxes Payable	54,365	1,386
Accrued Compensation	0	200,000
Accrued Interest	24,728	667,994
Net Cash Flows (Used in) Provided by From Operating Activities	-5,091,550	-2,823,296
Cash Flows from Investing Activities	'	'
Proceeds from Sale of Assets, Net of Direct Costs	0	7,520,197
Purchases of Tooling and Equipment	-145,929	-180,189
Investments in Software	-240,561	0
Investments in Patents and Trademarks	-72,704	-67,923
Net Cash (Used in ) Provided by From in Investing Activities	-459,194	7,272,085
Cash Flows from Financing Activities	'	'
Issuance of Common Stock in Public Offering	8,050,000	0
Direct Offering Associated Costs	-1,204,779	-57,500
Net Change in Lines of Credit	-112,500	-539,581
Repayment of Capital Leases	-55,733	-92,739
Repayment of Long-Term Debt and Short-Term Notes Payable	-2,137,983	-4,474,879
Issuance Costs of Senior Convertible Debt	-183,809	0
Proceeds from Exercise of Warrants	56,250	0
Proceeds from Senior Convertible Debt	1,000,000	0
Proceeds from Notes Payable	382,884	364,488
Net Cash Flows (Used in) Provided by Financing Activities	5,794,330	-4,800,211
Net Increase (Decrease) in Cash and Cash Equivalents	243,586	-351,422
Cash and Cash Equivalents — Beginning of Period	66,554	417,976
Cash and Cash Equivalents — End of Period	310,140	66,554
Supplemental Disclosures	'	'
Interest Paid	230,112	170,512
Income Taxes Paid	32,533	19,012
Non-Cash Investing and Financings Activities	'	'
Conversion of Accrued Compensation and Interest into Common Stock	1,642,569	0
Conversion of Term Debt and Accrued Interest into Common Stock	2,316,007	0
Warrant Derivative Liability of Common Stock Offering and Debt Conversions	8,236,786	0
Discount on senior convertible debenture attributed to warrants	732,584	0
Warrants granted to Senior Debt Holders for Early Debt Repayment	97,913	0
Warrants granted for senior convertible debenture issuance costs	$66,603	$0

Basis_of_Presentation

Basis of Presentation	12 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation Of Financial Statements [Abstract]	'
Basis of Presentation	'
	Note 1 — Basis of Presentation
	The results of the Company’s Tactical Display Group business have been classified and presented as discontinued operations in the accompanying Consolidated Statement of Operations (Note 4).
	All per share amounts, outstanding shares, warrants, options and shares issuable pursuant to convertible securities for all periods reflect the Company’s 1-for-75 reverse stock split, which was effective February 6, 2013.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	Note 2 — Summary of Significant Accounting Policies
	Operations
	Vuzix Corporation (the Company) was formed in 1997 under the laws of the State of Delaware and maintains its corporate offices in Rochester, New York. The Company is engaged in the design, manufacture, marketing and sale of devices that are worn like eyeglasses and which feature built-in video screens that enable the user to view video and digital content, such as movies, computer data, the Internet or video games. Our products (known commercially as “Video Eyewear”) are used to view high resolution video and digital information from portable devices, such as cell phones, portable media players, gaming systems and laptop computers and from personal computers. Our products provide the user with a virtual viewing experience that emulates viewing a large screen television or desktop computer monitor practically anywhere, anytime.
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Vuzix Europe and Vuzix Finland, OY. All significant inter-company transactions have been eliminated.
	Segment Data, Geographic Information and Significant Customers
	The Company is not organized by market and is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. The Company does not operate any material separate lines of business or separate business entities. Accordingly, the Company does not accumulate discrete information, other than product revenue and material costs, with respect to separate product lines and does not have separately reportable segments as defined by FASB ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information,”
	Shipments to customers outside of the United States approximated 36% and 27% of sales in 2013 and 2012, respectively. No single international country represented more than 10% of revenues. The Company does not maintain significant amounts of long-lived assets outside of the United States other than tooling held by its third party manufacturers, primarily in China.
	The Company has at times had a concentration of sales to the U.S. government, the majority of which was reported as discontinued operations and they amounted to approximately 17% and 11% of sales in 2013 and 2012, respectively. Accounts receivable from the U.S. government accounted for 79% and -0-% of accounts receivable at December 31, 2013 and 2012, respectively. Another customer, who is also a minority stockholder, represented -0-% and 10% of our total revenues, all of which was reported as sales from discontinued operations in 2012.
	Foreign Currency Transactions
	The U.S. dollar is the functional currency of the Company’s foreign subsidiaries. Gains and losses arising upon settlement of foreign currency denominated transactions or balances are included in the determination of income.
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at year end and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
	Concentration of Credit Risk
	The Company performs ongoing credit evaluations of its customers’ financial condition and maintains an allowance for uncollectible accounts receivable based upon the expected collectability of all accounts receivable.
	Cash and Cash Equivalents
	The Company’s cash received is applied against its revolving line of credit on a periodic basis based on projected monthly cash flows, reducing interest expense. Cash and cash equivalents can include highly liquid investments with original maturities of three months or less.
	Fair Value of Financial Instruments
	The Company’s financial instruments primarily consists of cash and cash equivalents, accounts receivable, inventories, prepaid expenses and other assets, accounts payable, lines of credit, current portion of long-term debt and capital leases, customer deposits, accrued expenses, and income taxes payable.
	As of the consolidated balance sheet date, the estimated fair values of the financial instruments were not materially different from their carrying values as presented due to the short maturities of these instruments and that the interest rates on the borrowing approximate those that would have been available for loans for similar remaining maturity and risk profiles at respective year ends.
	Allowance for Doubtful Accounts
	The Company establishes an allowance for uncollectible trade accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability of outstanding balances. These provisions are established when the aging of outstanding amounts exceeds allowable terms and are re-evaluated at each quarter end for adequacy. In determining the adequacy of the provision, the Company considers known uncollectible or at risk receivables.
	Provision for Future Warranty Costs
	Warranty costs are accrued, to the extent that they are not recoverable from third party manufacturers, for the estimated cost to repair or replace products for the balance of the warranty periods. The Company’s products are covered by standard warranty plans that extend normally 12 months to 24 months from the date of product shipment. The Company provides for the costs of expected future warranty claims at the time of product shipment or over-builds to cover replacements. The adequacy of the provision is assessed at each quarter end and is based on historical experience of warranty claims and costs.
	Inventories
	Inventories are valued at the lower of cost, or market using the first-in, first-out method. The Company does include direct overhead costs in its inventory valuation costing. The Company records provisions for excess, obsolete or slow moving inventory based on changes in customer demand, technology developments or other economic factors. The Company’s products have product life cycles that range on average from two to three years currently. At both the product introduction and product discontinuation stage, there is a higher degree of risk of inventory obsolescence. The provision for obsolete and excess inventory is evaluated for adequacy at each quarter end. The estimate of the provision for obsolete and excess inventory is partially based on expected future product sales, which are difficult to forecast for certain products.
	Revenue Recognition
	The Company recognizes revenue from product sales in accordance with FASB ASC Topic 605 “Revenue Recognition”. Product sales represent the majority of the Company’s revenue. The Company recognizes revenue from these product sales when persuasive evidence of an arrangement exists, delivery has occurred or services have been provided, the sale price is fixed or determinable, and collectability is reasonably assured. Additionally, the Company sells its products on terms which transfer title and risk of loss at a specified location, typically shipping point. Accordingly, revenue recognition from product sales occurs when all factors are met, including transfer of title and risk of loss, which typically occurs upon shipment by the Company. If these conditions are not met, the Company will defer revenue recognition until such time as these conditions have been satisfied. The Company collects and remits sales taxes in certain jurisdictions and reports revenue net of any associated sales taxes. The Company also sells certain products through distributors who are granted limited rights of return for stock balancing against purchases made within a prior 90 day period, including price adjustments downwards that the Company implements on any existing inventory. The provision for product returns and price adjustments is assessed for adequacy both at the time of sale and at each quarter end and is based on recent historical experience and known customer claims.
	Revenue from any engineering consulting and other services is recognized at the time the services are rendered. The Company accounts for its longer-term development contracts, which to date have all been firm fixed-priced contracts, on the percentage-of-completion method, whereby income is recognized as work on contracts progresses, but estimated losses on contracts in progress are charged to operations immediately. The percentage-of-completion is determined using the cost-to-cost method. Amounts are generally billed on a monthly basis. To date all such contracts have been less than one calendar year in duration.
	The Company recognizes software license revenue under ASC 985-605 “Software Revenue Recognition” and under ASC 605-25 “Revenue Arrangements with Multiple Deliverables”, and related interpretations, as amended. Licensed software may be sold as a stand-alone element, with other software elements, or in conjunction with hardware products. When the Company’s products consists of more than one element, it is considered to be a multiple element arrangement (MEA). When sold as a stand-alone element, the revenue is recognized upon shipment as discussed above. When sold as part of a MEA, revenue from the licensed software is recognized when the product and embedded software is shipped to the customer.
	For either a single element transaction or a MEA, the Company allocates consideration to all deliverables based on their relative stand-alone selling prices. Amendments to ASC 605-25, which became effective January 1, 2011, establish a hierarchy to determine the stand-alone selling price as follows:
		•	Vendor Specific Objective Evidence of the fair value (VSOE),
		•	Third Party Evidence (TPE)
		•	Best Estimate of the Selling Price (ESP)
	Sales which constitute a MEA are accounted for by determining if the elements can be accounted for as separate accounting units, and if so, by applying values to those units, per the hierarchy above. If VSOE is not available, management estimates the fair selling price using historical pricing for similar items, in conjunction with current pricing and discount policies.
	Revenue from licensed software is recognized upon shipment and in accordance with industry-specific software recognition accounting guidance. Software updates that will be provided free of charge are evaluated on a case-by-case basis to determine whether they meet the definition of an upgrade and create a multiple element arrangement. The consideration allocated to the unspecified software upgrade rights and non-software services is deferred and recognized rateably over the 24-month estimated life of the devices. The Company’s BESP for the unspecified software upgrade right and non-software services is $25 per unit for the M100 Smart Glass.
	Fees charged to customers for post-contract Technical Support are recognized ratably over the term of the contract. Costs related to maintenance obligations are expensed as incurred.
	Tooling and Equipment
	Tooling and equipment are stated at cost. Depreciation of tooling and equipment is provided for using the straight-line method over the following estimated useful lives:
	Computers and Software	3 years
	Manufacturing Equipment	5 years
	Tooling	3 years
	Furniture and Equipment	5 years
	Repairs and maintenance costs are expensed as incurred. Asset betterments are capitalized.
	Patents and Trademarks
	The Company capitalizes the costs of obtaining its patents and registration of Trademarks. Such costs are accumulated and capitalized during the filing periods, which can take several years to complete. Successful applications that result in the granting of a patent or trademark are then amortized over 15 years on a straight-line basis. Unsuccessful applications are written off and expensed in the fiscal period where the application is abandoned or discontinued.
	Software Development Costs
	The Company capitalizes the costs of obtaining its software once technological feasibility has been determined by management. Such costs are accumulated and capitalized and projects can take several years to complete. Unsuccessful or discontinued software projects are written off and expensed in the fiscal period where the application is abandoned or discontinued. Costs incurred internally in researching and developing a computer software product are charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. Generally, this occurs shortly before the products are released to manufacturing. The amortization of these costs is included in cost of revenue over the estimated life of the products, which currently is estimated as 3 years using a straight-line basis.
	Long-Lived Assets
	The Company regularly assesses all of its long-lived assets for impairment when events or circumstances indicate their carrying amounts may not be recoverable, in accordance with FASB ASC Topic 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets.” In 2013, an impairment charge of $73,423 was recorded related to abandoned patents and trademarks. In 2012, an impairment charge of $64,703 was recorded related to abandoned patents and trademarks.
	Research and Development
	Research and development costs, are expensed as incurred consistent with the guidance of FASB ASC Topic 730, “Research and Development,” and include employee related costs, office expenses, third party design and engineering services, and new product prototyping costs. Costs incurred internally in researching and developing a computer software product are charged to expense until technological feasibility has been established for the product.
	Shipping and Handling Costs
	Amounts charged to customers and costs incurred by the Company related to shipping and handling are included in net sales and cost of goods sold, respectively, in accordance with FASB ASC Topic 605-45, “Revenue Recognition – Principal Agent Consideration”, “Accounting for Shipping and Handling Fees and Costs.”
	Advertising
	Advertising costs are expensed as incurred and recorded in “Selling and Marketing” in the Consolidated Statements of Operations. Advertising expense for the years ended December 31, 2013 and 2012 amounted to $231,552 and $253,815, respectively. These amounts are inclusive of $4,500 in 2012 that are included in Discontinued Operations.
	Income Taxes
	The Company accounts for income taxes in accordance with FASB ASC Topic 740-10, “Income Taxes.” Accordingly, the Company provides deferred income tax assets and liabilities based on the estimated future tax effects of differences between the financial and tax bases of assets and liabilities based on currently enacted tax laws. A valuation allowance is established for deferred tax assets in amounts for which realization is not considered more likely than not to occur.
	The Company reports any interest and penalties accrued relating to uncertain income tax positions as a component of the income tax provision.
	Earnings Per Share
	Basic earnings per share is computed by dividing the net (loss) income less accrued dividends on any outstanding preferred stock by the weighted average number of common shares outstanding for the period. Diluted earnings per share calculations reflect the assumed exercise of all dilutive employee stock options and warrants applying the treasury stock method promulgated by FASB ASC Topic 260, “Earnings Per Share” and the conversion of any outstanding convertible preferred shares or notes payable that are-in-the-money, applying the as-if-converted method. However, if the assumed exercise of stock options and warrants and the conversion of any preferred shares or convertible notes payable are anti-dilutive, basic and diluted earnings per share are the same for all periods.
	Stock-Based Employee Compensation
	The Company accounts for share-based compensation to employees and directors in accordance with FASB ASC Topic 718 “Compensation Stock Expense,” which requires that compensation expense be recognized in the consolidated financial statements for share-based awards based on the grant-date fair value using a Black-Scholes valuation model of those awards. The Company uses the fair market value of our common stock on the date of each option grant based on market price of the Company’s common shares on the TSX Venture Exchange and since August 5, 2013 on the OTCQB. Stock-based compensation expense includes an estimate of forfeitures and is recognized over the requisite service periods of the awards on a straight-line or graded vesting basis, which is generally commensurate with the vesting term. As a result of the adoption of FASB ASC Topic 718, stock-based compensation expense associated with stock option grants for the years ending December 31, 2013 and 2012 was $159,272 and $172,233, respectively.
The Company issues new shares upon stock option exercises. Please refer to Note 22, Stock Option Plans, for further information.
Derivative Liability and Fair Value Measurements
The Company has adopted the provisions of FASB ASC Topic 820, “Fair Value Measurements and Disclosures” as of January 1, 2008 for financial instruments. This standard defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820 permits an entity to measure certain financial assets and financial liabilities at fair value with changes in fair value recognized in earnings each period. In accordance with ASC 815-10-25, we measured the derivative liability using a Lattice pricing model at their issuance date and subsequently they are remeasured. Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value. Derivatives that have more than one year remaining in their life are shown as long term derivative liabilities.
ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. Level 1 inputs are quoted prices in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are directly or indirectly observable for the asset or liability. Such inputs include quoted prices in active markets for similar assets and liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, or inputs derived principally from or corroborated by observable market data by correlation or other means. Level 3 inputs are unobservable inputs for the asset or liability. Such inputs are used to measure fair value when observable inputs are not available.
Recent Accounting Pronouncements
In December 2011, the FASB issued new guidance which requires enhanced disclosures on offsetting amounts within the balance sheet, including disclosing gross and net information about instruments and transactions eligible for offset or subject to a master netting or similar agreement. The guidance is effective for the company beginning January 1, 2013 and is to be applied retrospectively. The adoption of this guidance, which is related to disclosure only, did not have an impact on the company’s consolidated financial position, results of operations or cash flows.
There are no other recent accounting pronouncements that are expected to have a material impact on the consolidated financial statements.

Going_Concern_Issues

Going Concern Issues	12 Months Ended
	Dec. 31, 2013
Going Concern Disclosure [Abstract]	'
Going Concern Issues	'
	Note 3 —Going Concern Issues
	The Company’s independent registered public accounting firm’s report issued on our consolidated financial statements for the years ended December 31, 2013 and 2012 included an explanatory paragraph describing the existence of conditions that raise substantial doubt about the Company’s ability to continue as a going concern, including continued operating losses and the potential inability to pay currently due debts. The Company has incurred a net loss from continuing operations consistently over the last 2 years. The Company incurred annual net losses from its continuing operations of $10,146,228 in 2013 and $4,747,387 in 2012, and has an accumulated deficit of $36,292,532 as of December 31, 2013. The Company’s ongoing losses have had a significant negative impact on the Company’s financial position and liquidity.
	The Company’s cash requirements are primarily for funding operating losses, working capital, research, principal and interest payments on debt obligations, and capital expenditures. Historically, the Company has met these cash needs by borrowings under notes, sales of convertible debt, the sales of equity securities and the sale of assets. The major transactions over the last two years included:
		-	The sale of assets relating to the Company’s Tactical Display Group business (the “TDG Assets”) on June 15, 2012 and subsequent debt repayments and debt deferrals. The Company received net proceeds of $7,520,197.
		-	On March 21, 2013, the Company issued a five year secured 16% convertible debenture in the amount of $800,000. The entire principal amount and related accrued interest of this loan along with a $160,000 early repayment penalty was repaid upon the closing of the Company’s public offering on August 5, 2013.
		-	On July 15, 2013, the Company issued a five year secured 16% convertible debenture in the amount of $200,000. The entire principal amount and related accrued interest of this loan along with a $40,000 early repayment penalty was repaid upon the closing of the Company’s public offering on August 5, 2013.
		-	On August 5, 2013, the Company closed its public offering of 4,025,000 shares of common stock, and warrants to purchase up to an aggregate of 4,025,000 shares of common stock, at a public offering price of $2.00 per share and $0.0001 per warrant. The warrants have a per share exercise price of $2.25, are exercisable immediately, and expire 5 years from the date of issuance. Total gross proceeds from the public offering were $8,050,000, before underwriting discounts and commissions and other offering expenses payable by Vuzix of $1,358,641. Simultaneous with the closing of this public offering $2,316,007 in outstanding secured debt and accrued interest thereon, converted into common stock and warrants with the same material terms at a conversion price equal to the offering price of $2.00. Additionally $1,642,569 in outstanding long-term accrued compensation and accrued interest owed to our officers was converted into common stock and similar warrants at a conversion price equal to the offering price of $2.00.
	The above public offering and related debt conversions and repayments have allowed the Company to cure all its prior debt defaults. Since the closing of the public offering on August 5, 2013, the Company has had the financial resources to better execute on its business plans and reduced the doubt about its ability to continue as a going concern. However the Company’s continued operating losses and large composition of old accounts payable continues to affect the efficient operations of the Company and slows new product development.
	The Company’s cash requirements depend on numerous factors, including new product development activities, our ability to commercialize our products, their timely market acceptance, selling prices and gross margins, and other factors. To the extent the Company has sufficient operating funds, it expects to carefully devote capital resources to the development of new products and to continue its waveguide and HD display engine development programs, hire and train additional staff, and undertake new product marketing activities. Such expenditures, along with further future net operating losses, product tooling expenses, and related working capital investments, will be the principal use of cash. The Company must grow its business significantly to become profitable and self-sustaining on a cash flow basis or it will be required to raise new capital.
	The Company’s management intends to take actions necessary to continue as a going concern, as discussed herein, and accordingly our consolidated financial statements have been prepared assuming that we will continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Management’s plans concerning these matters and managing our liquidity includes among other things:
		•	managing working capital through better optimization of inventory levels;
		•	focusing on selling higher gross margin products, which will mean a greater emphasis on augmented reality and smart glasses products;
		•	the introduction of see-through waveguide and new higher resolution Video Eyewear;
		•	reducing operating costs wherever possible;
		•	minimizing capital expenditures by eliminating, delaying or curtailing discretionary and non-essential spending;
		•	deferring some research and development and delaying some planned new products based on new technology;
		•	exploring options with respect to new equity financings or debt borrowings; and
		•	exploring the licensing of our IP
	The Company and its management cannot make assurances as to whether any of these actions can be effected on a timely basis, on satisfactory terms or maintained once initiated, and even if successful, whether its liquidity plan will limit certain of our operational and strategic initiatives designed to grow the business over the long term or whether such initiatives will be limited by the availability of capital.
	Continued increases in product sales and engineering services will be important steps to achieving cash-flow positive operations. The Company in calendar 2014 is now effectively shipping all new models and products as compared to its offerings last year. However, if these products are not successful within a reasonable time period, we will have to raise additional capital to maintain operations and/or materially reduce our operating and new product development costs. New products incorporating our waveguide optics and HD resolution Video Eyewear products may be delayed as a result.
	If the Company is required to raise additional funds by selling additional shares of its capital stock, or securities convertible into shares of its capital stock, the ownership interest of existing shareholders may be diluted. The amount of dilution could be increased by the issuance of warrants or securities with other dilutive characteristics, such as full ratchet anti-dilution clauses or price resets. The Company can give no assurance that it will be able to obtain additional financing on favorable terms or at all. If it is unable to become profitable and self-sustaining on a cash flow basis and needs to obtain future external funding, the Company could be forced to delay, reduce or eliminate its research and development programs, future commercialization efforts or otherwise curtail its business, which could adversely affect its business prospects. These factors raise substantial doubt about our ability to continue as a going concern.

Discontinued_Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2013
Discontinued Operations and Disposal Groups [Abstract]	'
Discontinued Operations	'
	Note 4 — Discontinued Operations
	In an effort to improve working capital, cure then existing debt defaults and pay down debts, on June 15, 2012, the Company sold and licensed those of its assets (including equipment, tooling, certain patents and trademarks) (the “TDG Assets”) that comprised its tactical defense group, which engaged in the business of selling and licensing products and providing services, directly and indirectly, to military, defense and security organizations (the “Business”). We recorded a gain of $5,837,607 from the asset sale.
	In accordance with ASC 205-20, the sale of the TDG Assets have been accounted for as discontinued operation. Accordingly, the operating results of the TDG Assets for the years ended December 31, 2013 and 2012 have been reclassified as discontinued operations on the Consolidated Statement of Operations. Below is a summary of these results:
		For Years
		Ended December 31,
		2013		2012
	Sales of Products	$	—	$	1,768,754
	Sales of Engineering Services		—		358,921
	Total Sales		—		2,127,675
	Total Cost of Sales		—		1,273,907
	Gross Profit		—		853,768
	Operating Expenses:
	Research and Development		—		295,138
	Selling and Marketing		—		200,378
	General and Administrative		—		—
	Depreciation and Amortization		—		—
	Interest Expense on Senior Debt*		—		353,584
	Amortization Senior Debt Discount*		—		752,248
	Income (Loss) from Discontinued Operations		—		-747,580
	Gain (Loss) on Disposal of Discontinued Operations		—		5,837,607
	Provision (Benefit) for Income Taxes (Note 21)		—		19,800
			—		5,817,807
	Net Income (Loss) from Discontinued Operations	$	—	$	5,070,227
	Basic Income (Loss) per Share	$	—	$	1.43
	Diluted Income (Loss) per Share	$	—	$	1.43
	Weighted-average Shares Outstanding Basic (Note 6)		—		3,536,865
	Weighted-average Shares Outstanding Diluted (Note 6)		—		3,651,100
	* Amounts reported represent the interest expense and the amortization of the discount on the Senior Term debt that was required to be repaid from the proceeds of the TDG Asset sale.

Gain_on_Asset_Disposal

Gain on Asset Disposal	12 Months Ended
	Dec. 31, 2013
Gain (Loss) On Disposition Of Assets [Abstract]	'
Gain on Asset Disposal	'
	Note 5 — Gain on Asset Disposal
	In an effort to improve working capital, cure then existing debt defaults and pay down debts, on June 15, 2012, the Company entered into an Asset Purchase Agreement (the “Agreement”) between the Company and TDG Acquisition Company, LLC, a Delaware limited liability company (“TDG”). Pursuant to the Agreement, the Company sold and licensed those of its assets (including equipment, tooling, certain patents and trademarks) (the “TDG Assets”) that comprised its tactical defense group, which engaged in the business of selling and licensing products and providing services, directly and indirectly, to military, defense and security organizations (the “Business”). The Business included sale of the Company’s proprietary Tac-Eye displays and its night vision electronics and optics module products. The Company received a worldwide, royalty free, assignable grant-back license to all the patents and other intellectual property sold to TDG, for use in the manufacture and sale of products other than in the military, defense and security markets. The Company retained the right to sell goods and services to other end user consumers, and to TDG and TDG and the Company jointly received the right to sell goods and services into all markets other than the military, defense and security markets and the consumer market. Each party agreed to refer to the other, business opportunities for the sale of products and services in its markets. Also pursuant to the Agreement, the Company and TDG entered into a Vuzix Authorized Reseller Agreement, pursuant to which TDG is authorized as the exclusive reseller of the Company’s current and future products to military, defense and security organizations, unless TDG elects to have the Company make such sales directly.
	The purchase price paid to the Company by TDG consists of two components: $8,345,793 net of adjustments, which was paid at closing, and up to an additional $2.5 million, which would be received only if TDG achieves certain quarterly and annual revenue targets from sales of goods and services to military, defense and security organizations. None of the $2.5 million was received during the measurement period.  The purchase price was determined by arm’s length negotiations between the parties.
	The following represents the major components of the reported gain on sale:
	Net Sales Price	$	8,345,793
	Less:
	Professional Fees on Sale of Assets		-825,596
	Accounts Receivable Sold		-299,599
	Inventories Sold		-1,135,042
	Tooling & Equipment Sold		-120,832
	Patents and Trademarks Sold		-113,117
	Federal Income Tax		-19,800
	Sales Taxes on Asset Sale		-14,000
	Net Gain on Sale of Asset	$	5,817,807

Net_Earnings_Loss_Per_Share_EP

Net Earnings (Loss) Per Share (EPS)	12 Months Ended
	Dec. 31, 2013
Earnings (Loss) Per Share	'
Net Earnings (Loss) Per Share (EPS)	'
	Note 6 — Net Earnings (Loss) Per Share (EPS)
	ASC 260-10 “Earnings Per Share” requires the Company to calculate its net income (loss) per share based on basic and diluted net income (loss) per share, as defined. Basic EPS excludes dilution and is computed by dividing net income (loss) by the weighted average number of shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. The dilutive effect of outstanding options and warrants issued by the Company, are reflected in diluted EPS using the treasury stock method. Under the treasury stock method, options and warrants will generally have a dilutive effect when the average market price of common stock during the period exceeds their exercise price. The dilutive effect of any outstanding convertible debt issued by the Company is reflected in diluted EPS using the if-converted method. For periods of net loss, basic and diluted EPS are the same as the assumed exercise of stock options and warrants and the conversion of convertible debt are anti-dilutive.
			Year Ended December 31,
			2013		2012
	Net (Loss) from Continuing Operations (A)		$	-10,146,228	$	-4,747,387
	Net Income (Loss) (B)		$	-10,146,228	$	322,840
	Add - Interest savings from converted debt			—		114,537
	Adjusted Diluted Net Income (Loss) (F)		$	-10,146,228	$	437,377
	Weighted Average Shares Outstanding:
	Weighted average basic shares outstanding (C)			5,988,595		3,536,865
	Dilutive effect of options and warrants			2,984,199		31,354
	Dilutive effect of convertible debt			-		82,881
	Weighted Average Dilutive Shares Outstanding (D)			8,972,794		3,651,100
	Earnings (Loss) Per Share From Continuing Operations
	Basic (A/C)		$	-1.69	$	-1.34
	Diluted (1) (2)		$	-1.69	$	-1.34
	Earnings (Loss) Per Share
	Basic (B/C)		$	-1.69	$	0.09
	Diluted (F/D) (1)		$	-1.69	$	0.09
		-1	Due to net loss for period, dilutive loss per share is the same as basic.
		-2	Due to the antidilutive impact of the convertible debt under the if-converted method, the diluted earnings per share is the same as basic.

Accounts_Receivable_Net

Accounts Receivable, Net	12 Months Ended
	Dec. 31, 2013
Accounts Receivable, Net [Abstract]	'
Accounts Receivable, Net	'
	Note 7 — Accounts Receivable, Net
	Accounts receivable consisted of the following:
		December 31,		December 31,
		2013		2012
	Accounts Receivable	$	214,920	$	170,600
	Less: Allowance for Doubtful Accounts		—		—
	Net	$	214,920	$	170,600

Inventories_Net

Inventories, Net	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
Inventories, Net	'
	Note 8 — Inventories, Net
	Inventories consisted of the following:
		December 31,		December, 31,
		2013		2012
	Purchased Parts and Components	$	1,094,250	$	945,550
	Work in Process		153,065		46,259
	Finished Goods		280,279		259,112
	Less: Reserve for Obsolescence		-573,967		-563,740
	Net	$	953,627	$	687,181

Deferred_Offering_Costs

Deferred Offering Costs	12 Months Ended
	Dec. 31, 2013
Deferred Offering Costs Disclosure [Abstract]	'
Deferred Offering Costs	'
	Note 9 — Deferred Offering Costs
	Deferred offering costs consist principally of legal, accounting and underwriters’ fees incurred related to the public offering of the Company’s common stock and warrants as discussed in Note 3, which were charged to capital as of the completion of the offering  on August 5, 2013.
		December 31,		December 31,
		2013		2012
	Professional and agents’ fees paid	$	—	$	57,500
	Professional and agents’ fees included Accrued Expenses		—		142,071
	Total	$	—	$	199,571

Tooling_and_Equipment_Net

Tooling and Equipment, Net	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment, Net [Abstract]	'
Tooling and Equipment, Net	'
	Note 10 — Tooling and Equipment, Net
	Tooling and equipment consisted of the following:
		December 31,		December 31,
		2013		2012
	Tooling and Manufacturing Equipment	$	1,748,006	$	1,685,006
	Computers and Software		645,429		615,567
	Furniture and Equipment		749,233		763,134
		$	3,142,668	$	3,063,707
	Less: Accumulated Depreciation		-2,696,339		-2,398,740
	Net	$	446,329	$	664,967
	Total depreciation expense for tooling and equipment for the years ending December 31, 2013 and 2012 was $322,861 and $409,421, respectively.

Patents_and_Trademarks_Net

Patents and Trademarks, Net	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Patents and Trademarks, Net	'
	Note 11 — Patents and Trademarks, Net
		December 31,		December 31,
		2013		2012
	Patents and Trademarks	$	777,593	$	803,687
	Less: Accumulated Amortization		-281,985		-252,380
	Net	$	495,608	$	551,307
	Total amortization expense for patents and trademarks for the years ending December 31, 2013 and 2012 it was $54,979 and $59,396, respectively. The estimated aggregate annual amortization expense for each of the next five fiscal years is $50,058. We recorded an impairment charge of $73,423 representing cost of $98,798, less accumulated amortization of $25,375 for the year ending December 31, 2013. We recorded an impairment charge of $64,703 representing cost of $171,868, less accumulated amortization of $107,165 for the year ending December 31, 2012 regarding our abandoned patents and trademarks.

Software_Development_Costs

Software Development Costs	12 Months Ended
	Dec. 31, 2013
Research and Development [Abstract]	'
Software Development Costs, Net	'
	Note 12 — Software Development Costs
		December 31,		December 31,
		2013		2012
	Software Development Costs	$	240,561	$	—
	Less: Accumulated Amortization		—		—
	Net	$	240,561	$	—
	Total amortization expense for capitalized software development costs for the years ending December 31, 2013 and 2012 was $-0-, respectively. These costs will be amortized over 3 years.  No amortization was recorded in 2013 because the related software project was not completed as of December 31, 2013.

Lines_of_Credit

Lines of Credit	12 Months Ended
	Dec. 31, 2013
Line Of Credit Facility [Abstract]	'
Lines Of Credit	'
	Note 13 — Lines of Credit
	The Company has available a $112,500 line of credit with interest payable at the bank’s prime rate plus 1%. The line is unsecured and personally guaranteed by an officer of the Company. The outstanding balance on this line of credit amounted to $-0- and $112,500 at December 31, 2013 and 2012, respectively.

Notes_Payable

Notes Payable	12 Months Ended
	Dec. 31, 2013
Notes Payable [Abstract]	'
Notes Payable	'
	Note 14 — Notes Payable
	Notes payable represent promissory notes payable by the Company.
		December 31,		December 31,
		2013		2012
	Note payable to officers and shareholders of the Company. Principal along with accrued interest is payable on demand and paid on December 31, 2014. The notes bear interest at 18.5% and secured by all the assets of the Company.	$	229,787	$	165,738
	Note payable secured by all the assets of Company and the guarantee of its President and CEO. The effective interest rate is 31%. The note is to be repaid in 12 blended monthly payments of $5,645.		37,383		46,737
	Note payable to an officer of the Company due on December 31, 2013. The note bears interest at 7.49% and monthly principal payments of $2,691 plus accrued interest are required. The note is secured by all the assets of the Company.		11,297		45,734
		$	278,467	$	258,209

Customer_Deposits

Customer Deposits	12 Months Ended
	Dec. 31, 2013
Deposits, By Customer, Alternative [Abstract]	'
Customer Deposits	'
	Note 15 — Customer Deposits
	Customer deposits represents money the Company received in advance of providing a product or engineering services to a customer. These deposits include against unfulfilled deliverables of multiple-element products, including unspecified post-delivery support and software updates. Included in Customer Deposits is Unearned Revenue of $39,700 as of December 31, 2013 as compared to $-0- in 2012. All such deposits are short term in nature as the Company delivers the product, unfulfilled portions or engineering services to the customer before the end of its next annual fiscal period. These deposits are credited to the customer against product deliveries or at the completion of their order.

Accrued_Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2013
Payables and Accruals [Abstract]	'
Accrued Expenses	'
	Note 16 — Accrued Expenses
	Accrued expenses consisted of the following:
		December		December
		31, 2013		31, 2012
	Accrued Wages and Related Costs	$	91,385	$	31,197
	Accrued Compensation		360,670		181,322
	Accrued Professional Services		69,500		181,227
	Accrued Warranty Obligations		31,619		93,788
	Other Accrued Expenses		1,090		32,138
	Total	$	554,264	$	519,672
	The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally one year except in European countries where it is two years. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. The Company estimates its future warranty costs based on product-based historical performance rates and related costs to repair.
	The changes in the Company’s accrued warranty obligations for the years ended December 31, 2013 and 2012 were as follows:
	Accrued Warranty Obligations at December 31, 2011	$	118,611
	Reductions for Settling Warranties		-126,308
	Warranty Issued During Year		101,485
	Accrued Warranty Obligations at December 31, 2012	$	93,788
	Reductions for Settling Warranties		-74,287
	Warranty Issued During Year		12,118
	Accrued Warranty Obligations at December 31, 2013	$	31,619

Derivative_Liability_and_Fair_

Derivative Liability and Fair Value Measurements	12 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Liability and Fair Value Measurements	'
	Note 17 – Derivative Liability and Fair Value Measurements
	The Company recognized a derivative liability for the warrants to purchase 186,480 shares of its common stock issued in connection with the $800,000 convertible senior secured debenture issued on March 21, 2013. These warrants have a cashless exercise provision effective six months after the issuance date and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) within the first six months. In accordance with ASC 820-10-35 we measured the derivative liability using a Black-Scholes pricing model at the March 21, 2013 issuance date. On September 21, 2013, the exercise price adjustment feature expired causing the warrants to no longer require derivative accounting treatment. Accordingly the derivative liability was marked to market on September 21, 2013 and the fair value of $526,245 related to these warrants was reclassified to Additional Paid-in Capital. See Note 23: Warrants for additional information on the warrants issued.
	The Company recognized a derivative liability for the warrants to purchase 38,168 shares of its common stock issued in connection with the $200,000 convertible senior secured debenture issued on July 15, 2013. These warrants have a cashless exercise provision effective six months after the issuance date and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) within the first six months. In accordance with ASC 815-10-25, we measured the derivative liability using a Monte Carlo Options Lattice pricing model at the July 15, 2013 issuance date and subsequently remeasured the liability on December 31, 2013. See Note 23: Warrants for additional information on the warrants issued.
	The Company recognized a derivative liability for the warrants to purchase 6,004,288 shares of its common stock issued in connection with the equity offering and related debt conversions issued on August 5, 2013. These warrants have a cashless exercise provision and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) along with full-ratchet anti-dilution provisions. In accordance with ASC 815-10-25, we measured the derivative liability using a Lattice pricing model at the August 5, 2013 issuance date and subsequently remeasured the liability on December 31, 2013. See Note 23: Warrants for additional information on the warrants issued.
	The Company recognized a derivative liability for the warrants to purchase 127,717 shares of its common stock issued in connection with obtaining the permission of the Company’s senior debt holders for its August 5, 2013 public equity offering. These warrants have a cashless exercise provision effective six months after the issuance date and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) within the first six months. In accordance with ASC 815-10-25, we measured the derivative liability using a Lattice pricing model at the August 5, 2013 issuance date and subsequently remeasured the liability on December 31, 2013. On September 21, 2013 the exercise price adjustment feature expired for 102,357 of these warrants, causing these warrants to no longer require derivative accounting treatment. Accordingly the associated derivative liability was marked to market on September 21, 2013 and these warrants were reclassified to Additional Paid-in Capital. The remaining 25,360 warrants were subsequently remeasured as December 31, 2013. See Note 23: Warrants for additional information on the warrants issued.
	Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value. The total derivative liability was revalued to $12,035,816 based on the closing price of our common shares as of December 31, 2013, resulting in a loss of  $3,575,278 on the derivative’s valuation for the year ending December 31, 2013 and $-0- for the same period in 2012.
	The Company concluded that the Put embedded in the senior secured convertible debentures in the event of the Company’s default under the Debenture had such minimal value that it did not record an additional and separate liability for this contingency. Both debentures were repaid in full on August 5, 2013.
	The Company has adopted ASC Topic 820 (originally issued as SFAS 157, “Fair Value Measurements”) for financial instruments measured at fair value on a recurring basis. ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:
	-     Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
	-     Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
	-     Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 30, 2013:
		Total			(Level 1)			(Level 2)		Level (3)
	Assets	$	—		$	—		$	—	$	—
	Total assets measured at fair value		—			—			—		—
	Liabilities
	Derivative Liability		12,035,816			—			—		12,035,816
	Total liabilities measured at fair value (Long-Term)	$	12,035,816		$	—		$	—	$	12,035,816
		December			December
		31, 2013			31, 2012
	Fair value – beginning of period	$	—		$	—
	Warrants issue		9,067,283			—
	Reclassification of warrant liabilities to Additional Paid-in Capital		-526,245			—
	Reclassification of warrant exercises to Additional Paid-in Capital		-80,500			—
	Change in fair value		3,575,278			—
	Fair value – end of period	$	12,035,816		$	—
	For year ending December 30, 2013, the Monte Carlo Options Lattice pricing model was used to estimate the fair value of warrants issued during this period. The following summary table shows the assumptions used to compute the fair value of the warrants granted during 2013 at issuance and as of December 31, 2013 is:
		December 31, 2013				At Issuance
	Assumptions for Pricing Model:
	Expected term in years		4.2 to 4.6				4.62 to 5.0
	Volatility range for years 1 to 5		56	%			61 to 110	%
	Risk-free interest rate		1.75	%			0.77 to 1.41	%
	Expected annual dividends		None				None
	Value of warrants issued:
	Fair value of warrants	$	12,035,816			$	9,067,283

Accrued_Compensation

Accrued Compensation	12 Months Ended
	Dec. 31, 2013
Compensation Related Costs [Abstract]	'
Accrued Compensation	'
	Note 18 — Accrued Compensation
	Accrued compensation represents amounts owed to officers of the Company for services rendered that remain outstanding. The principal is not subject to a fixed repayment schedule, and interest on the outstanding balances is payable at 8% per annum, compounding monthly. The respective interest amounts are included in Accrued Interest, under the Long-Term Liabilities. The unpaid principal amounts are shown as Long-Term Liabilities on the consolidated balance sheet.
		Accrued		Accrued Interest
		Compensation
	Balance as at December 31, 2011	$	810,096	$	339,323
	Additions 2012		200,000		103,315
	Subtractions 2012		—		—
	Balance as at December 31, 2012		1,010,096		442,638
	Additions 2013		116,667		73,168
	Subtractions 2013		-1,126,763		-515,806
	Balance as at December 31, 2013	$	—	$	—
	On March 27, 2013, the Company entered into a deferred compensation deferral and conversion option agreements with two of its officers, which agreements were subject to the closing of the Company’s planned public stock offering and which agreements were effective upon such closing on August 5, 2013. Pursuant to those agreements the officers each converted the entire long-term portion their deferred compensation amounts plus accrued interest into shares of the Company’s common stock and related warrants, at the conversion price of $2.00, equal to the offering price of the Company’s August 5, 2015 public stock offering.  Current accrued compensation and general accrued wages as at December 31, 2013 and 2012 is included in Accrued Expenses – please refer to Note 16.

LongTerm_Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Long-Term Debt	'
	Note 19 — Long-Term Debt
	Long-term debt consisted of the following at December 31:
			December 31,			December
			2013			31, 2012
	Note payable to an officer of the Company. The principal was not subject to a fixed repayment schedule, bore interest at 8% per annum and was secured by all of the assets of the Company		$	—		$	209,208
	Note payable to an officer of the Company. The principal and interest was subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bore interest at 12% per annum and was secured by a subordinated position in all the assets of the Company.			—			225,719
	Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2012 over 48 months.			256,727			396,004
	The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.			-71,701			-97,003
	Convertible, Senior Secured Term Debt. The principal was to be repaid over 15 months, with equal payments of principal beginning on October 15, 2012. The Company did not make any of the required principal payments and was in default. The loan bore interest at 13.5%, per annum, which was payable monthly on the 15th of each month. The loan was secured by a first security position in all the Intellectual Property assets of the Company and a security interest in all of the other assets of the Company that was subordinate only to the security interest that secures the Company’s working capital loan.			—			619,122
	Long-term secured deferred trade payable for which the principal and interest was subject to a fixed blended repayment schedule of 24 and 36 months, commencing July 15, 2013. The deferred trade payable bears interest at 12% per annum and was secured by a subordinated position in all the assets of the Company.			—			1,320,643
	Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per annum and is secured by a subordinated position in all the assets of the Company.			84,790			101,748
			$	269,816		$	2,775,441
	Less: Amount Due Within One Year			-99,320			-1,060,188
	Amount Due After One Year		$	170,496		$	1,715,253
	The aggregate maturities reflect future cash principle payments exclusive of non-cash amortization discount for all long-term borrowings as of December 31, 2013 are as follows:
	2014			2015			2016		2017		Thereafter		Total
	$	99,320		$	100,064		$	70,432	$	—	$	—	$	269,816
	In connection with the sale of the TDG Assets, certain of the Company’s lenders entered into Loan Modification and Consent agreements pursuant to which each consented to the sale, as required by the loan agreements between the Company and each such lender, and released their security interests in the TDG Assets sold. Pursuant to a Loan Modification and Consent Agreement regarding the Company’s Convertible, Senior Secured Term Debt Loan, which was in default at the time of the sale, the Company paid this Senior Lender $4,450,000 in reduction of the obligations of the Company to the Senior Lender. The obligation of the Company to repay the remaining amount due to the Convertible Senior Secured Term Debt Lender, $619,122 was represented by a new note in that amount. This new note carried an interest rate of 13.5%, to be paid monthly. The principal amount of the note was to be repaid over 15 months, with equal principal payments commencing on October 15, 2012. The Company did not make any of its required principal payments. The note plus accrued interest was repaid in full on August 5, 2013.
	Pursuant to its original transaction with the holder of the Senior Secured Term Debt, the Company issued to that lender warrants to purchase up to 533,333 shares of common stock (the “Warrants”), at an exercise price of $7.47 per share, exercisable at any time prior to December 23, 2014. The fair value of these Warrants, $1,010,379 was reflected as a discount against the loan amount, but because of the loan’s restructuring and the early repayment of the principal resulting from the TDG Assets sale, the unamortized discount of $636,678 was fully expensed in the second quarter of 2012.
	Pursuant to the various other Loan Modification and Consent agreements, each secured term note payable holder agreed to defer further payments on their respective Note Payable due from the Company until July 15, 2013 after which the notes were to be repaid in 24 to 36 equal monthly installments.
	On March 27, 2013, and amended thereafter, the Company entered into several debt conversion agreements with the respective holders of $2,374,682 of the long-term debt reflected in table above. Pursuant to the agreements, each lender agreed to convert its outstanding secured promissory note, together with accrued interest thereon into shares of the Company’s common stock, subject to the closing of the Company’s proposed public stock offering, at a conversion price equal to the public offering price. In connection with the closing of the public offering on August 5, 2013, $1,755,570 of these loan amounts plus accrued interest were converted to shares of common stock and warrants and the remainder was repaid.
	On March 21, 2013, the Company entered into a Securities Purchase Agreement with Hillair Capital Management L.P. (Hillair), pursuant to which, on March 21, 2013, the Company issued to Hillair a $800,000 16% secured convertible debenture due March 21, 2018. The debenture bore interest at a rate of 16% per year, payable quarterly in cash or shares of common stock at the Company’s option. Commencing on February 1, 2014, the Company was required to redeem a certain amount under the debenture on a periodic basis in an amount equal to $200,000 on each of February 1, 2014, May 1, 2014 and August 1, 2014 and $50,000 on each of August 1, 2015, August 1, 2016, August 1, 2017 and March 21, 2018, until the debenture’s maturity date of March 21, 2018; payable in cash or common stock at our option subject to certain conditions. The debenture was convertible into shares of our common stock at a conversion price of $4.29 per share, subject to certain conversion price adjustments. In connection with the debenture issuance, the Company also issued to Hillair five-year warrants to purchase 186,480 shares of its common stock at an initial exercise price of $4.72 per share, which was subject to exercise price adjustments for only the first six months. Upon the closing of the public offering, the warrant exercise was reduced to $2.25. The warrants were reflected as a derivative liability on the balance sheet and recorded as a discount against the debenture. See Note 17 for further details. Upon the closing of the public offering on August 5, 2013, the debenture principal and accrued interest was repaid along with an early repayment penalty of $160,000, and the warrant exercise was reduced to $2.25.
	On July 15, 2013, the Company entered into a Securities Purchase Agreement with Hillair, pursuant to which the Company issued to Hillair a $200,000 senior secured convertible debenture due March 21, 2018, and (ii) a common stock purchase warrant to purchase up to 38,168 shares of our common stock at an initial exercise price of $5.24 per share, which is subject to exercise price adjustments for the first six months. The warrants may be exercised at any time on or after July 15, 2013 until March 21, 2018. The warrants were reflected as a derivative liability on the balance sheet and recorded as a discount against the debenture.  The debenture was convertible into shares of common stock at a conversion price of $5.24 per share, subject to adjustments upon certain events. Interest on the Debenture accrued at the rate of 16% annually and was payable quarterly on February 1, May 1, August 1 and November 1, beginning on August 1, 2013, on any redemption, conversion and at maturity. Interest was payable in cash or at the Company’s option in shares of our common stock, provided certain conditions are met. Commencing on February 1, 2014, the Company would have been obligated to redeem a certain amount under the debenture on a periodic basis in an amount equal to $50,000 on each of February 1, 2014, May 1, 2014 and August 1, 2014 and $12,500 on each of August 1, 2015, August 1, 2016, August 1, 2017 and March 21, 2018, until the debenture’s maturity date of March 21, 2018. Upon the closing of the public offering on August 5, 2013, the debenture principal and accrued interest was repaid along with an early repayment penalty of $40,000, and the warrant exercise was reduced to $2.25.
	Upon closing of the debenture transaction, the Company retained Gentry Capital Advisors LLC (Gentry) as a financial advisor and agreed to pay Gentry a fee of $50,000 over a period of 4 months commencing upon the closing. The Company also issued to Gentry five-year warrants to purchase 20,000 shares of common stock at an exercise price of $4.72 per share. The fair value of these warrants upon grant was calculated as $66,603 and was reflected in the deferred debenture issuance costs. In connections with the issuance of the two debentures the Company incurred issuance costs which totaled $257,691, inclusive of the financial advisor’s warrant discussed above. These costs will be amortized on a straight-line basis over the five year life of the debenture.
	The Company used cash from the August 5, 2013 offering for the repurchase and cancellation of the two debentures. As a result of the two debt repayments above, the Company incurred a loss on debt extinguishment of $1,272,296 which also includes $240,637 of unamortized capitalized debt issuance costs and $685,965 of unamortized debt discounts which were written-off.

Capital_Lease_Obligations

Capital Lease Obligations	12 Months Ended
	Dec. 31, 2013
Capital Lease Obligations [Abstract]	'
Capital Lease Obligations	'
	Note 20 — Capital Lease Obligations
	The Company maintains equipment held under capital lease obligations due in monthly installments ranging from $1,419 to $2,049 including interest at rates ranging from 25.15% to 26.71%. The related equipment is collateral to the leases. Final payments are due through September 2015.
		December 31,		December 31,
		2013		2012
	Total Principal Payments	$	41,552	$	97,285
	Less: Amount Due Within One Year		-24,670		-57,244
	Amount Due After One Year	$	16,882	$	40,041
	Annual requirements for retirement of the capital lease obligations are as follows:
	December 31,	Amount
	2014	$	31,687
	2015		18,445
	Total Minimum Lease Payments	$	50,132
	Less: Amount Representing Interest		-8,580
	Present Value of Minimum Lease Payments	$	41,552
	The following is a summary of assets held under capital leases:
	December 31,	2013		2012
	Computers and Software	$	30,692	$	96,925
	Furniture and Equipment		35,083		92,446
		$	65,775		189,371
	Less: Accumulated Depreciation		-52,275		-81,190
	Net	$	13,500	$	108,181
	Depreciation expense related to the assets under capital lease amounted to $17,247 and $34,433 for years ended December 31, 2013 and 2012, respectively.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Note 21 — Income Taxes
	The Company files U.S. federal and U.S. state tax returns. At December 31, 2013, the Company had unrecognized tax benefits totaling $11,405,522, of which would have a favorable impact on our tax provision (benefit), if recognized.
	Pre-tax earnings consisted of the following for the years ended December 31, 2013 and 2012:
	December 31,	2013			2012
	Total Pre-Tax (Loss) Earnings	$	-10,146,228		$	382,838
	The provision (benefit) for income taxes for the years ended December 31, 2013 and 2012 was as follows:
		2013			2012
	Current Income Tax Provision (Benefit)
	Federal – (all related to Gain on Sale of Discontinued Operations)	$	—		$	19,800
	State and Foreign		—			—
	State Tax Credit Refund		—			—
	Net Change in Liability for Unrecognized Tax Benefits		—			—
		$	—		$	19,800
	Deferred Provision (Benefit)		—			—
	Total Provision (Benefit)	$	—		$	19,800
	A reconciliation of the statutory U.S. federal income tax rate to the effective rates for the years ended December 31, 2013 and 2012 is as follows:
		2013				2012
	Federal Income Tax at Statutory Rate		34.4	%			34	%
	State Tax Provision, Net of Federal Benefit		0.5	%			3.5	%
	Foreign Income Taxed at Other Than 34%		-0.2	%			0	%
	Meals and Entertainment		0	%			1.4	%
	Stock Compensation Expense		-0.6	%			16.1	%
	Research and Development Credits		-0.2	%			4.2	%
	Loss on Derivative Valuation		-12.2	%			0	%
	Debt Discount		-0.2	%			0	%
	Officer’s Life Insurance		0	%			0.3	%
	Change in Rate Assumptions		41	%			-114.5	%
	Adjustments to Prior Year Tax Credits		0.7	%			-11.6	%
	Effective Tax Rate		63.2	%			-66.6	%
	Change in Valuations Allowance		-63.2	%			77.7	%
	Net Effective Tax Rate		0	%			11.1	%
	Deferred tax assets (liabilities) for the years ended December 31, 2013 and 2012 consist of the following:
		2013			2012
	Inventory and Inventory Related Items	$	196,871		$	234,000
	Warranty Reserves		10,845			32,000
	Accrued Interest		9,673			152,000
	Accrued Services		-1,887			28,000
	Accrued Loss Contingency		—			9,000
	Accrued Officer Compensation		111,276			—
	Net Operating Loss Carryforwards		9,739,496			2,881,000
	Accrued Compensation		—			405,000
	Amortization		-143,364			—
	(Gain)Loss on Fixed Assets		100,464			—
	Patents Costs and Loss on Abandonment or Sale of Patents		-81,093			—
	Charitable Contributions		2,487			—
	Unrealized Gains/Losses		47,049			—
	Tax Credit Carryforwards		1,466,429			1,399,000
	Depreciation		7,832			11,000
	Total Gross Deferred Tax	$	11,466,078		$	5,151,000
	Valuation Allowance — 100%		-11,466,078			-5,151,000
	Net Deferred Tax	$	—		$	—
	As of December 31, 2013, the Company has available $ 28,395,033 in net operating loss carryforwards which will begin to expire in 2018 if not utilized.
	As the result of the assessment of the FASB ASC 740-10 (Prior Authoritative Literature: FASB Interpretation No. 48 (“FIN 48”), Accounting for Uncertainty in Income Taxes — An Interpretation of FASB Statement No. 109), the Company has no unrecognized tax benefits. By statute, tax years 2010 -2013 are open to examination by the major taxing jurisdictions to which the Company is subject.
	Cash paid for income taxes during the years ended December 31, 2013 and December 31, 2012 were $ 32,533 and $19,012, respectively.
	FASB ASC 740 (Prior Authoritative Literature: SFAS No. 109, Accounting for Income Taxes), requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differing treatment of items for financial reporting and income tax reporting purposes. The deferred tax balances are adjusted to reflect tax rates by tax jurisdiction, based on currently enacted tax laws, which will be in effect in the years in which the temporary differences are expected to reverse. We have provided deferred income tax benefits on net operating loss carry-forwards to the extent we believe we will be able to utilize them in future tax filings.

Preferred_Stock

Preferred Stock	12 Months Ended
	Dec. 31, 2013
Preferred Stock Disclosure [Abstract]	'
Preferred Stock	'
	Note 22 — Preferred Stock
	Preferred stock
	Shares of undesignated preferred stock may be issued in one or more series. The Board of Directors is authorized to establish and designate the different series and to fix and determine the voting powers and other special rights and qualifications. A total of 5,000,000 shares of preferred authorized are authorized as of December 31, 2013 and December 31, 2012. There were 0 shares issued or outstanding on December 31, 2013 and 2012. There were no preferred dividends owing as of December 31, 2013 or 2012.

Stock_Warrants

Stock Warrants	12 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Stock Warrants	'
	Note 23 — Stock Warrants
	The following table shows the various changes in warrants for the years December 31, 2013 and 2012. A total of 6,551,654 warrants were issued during in 2013, with an aggregate fair value of $9,067,283, see Note 17 for further details. A total of 206,420 warrants were re-priced to $2.25 from $4.72 and 38,168 warrants were re-priced to $2.25 from $5.24 upon the closing of the public offering on August 5, 2013.
		December 31,		December 31,
		2013		2012
	Warrants Outstanding, Beginning of Year		656,641		867,628
	Exercised During the Year		-59,300		—
	Issued During the Year		6,551,654		—
	Forfeited During the Year		-1,220		-210,987
	Warrants Outstanding, End of Year		7,147,775		656,641
	The outstanding warrants as of December 31, 2013 expire from December 31, 2014 to August 5, 2018. The weighted average remaining term of the warrants is 4.2 years. The weighted average exercise price is $2.75 per share.

Stock_Option_Plans

Stock Option Plans	12 Months Ended
	Dec. 31, 2013
Stock Option Plans [Abstract]	'
Stock Option Plans	'
	Note 24 — Stock Option Plans
	The Company has the following Stock Option Plans (the “Plan”) that allow for the granting of both statutory and incentive stock options or ISOs, which can result in potentially favorable tax treatment to the participant, and non-statutory stock options. The exercise price per share subject to an option is determined by the administrator, but in the case of an ISO must not be less than the fair market value of a share of our common stock on the date of grant and in the case of a non-statutory stock option must not be less than 100% of the fair market value of a share of our common stock on the date of grant.
		2007 Plan		2009 Plan		Total
	Outstanding as of December 31, 2013	79,009		135,509		214,518
	Available for future issuance under plan	—		342,420		342,420
	Totals authorized by plan	79,009		477,929		556,938
	The Plan gives the Board of Directors of the Company the ability to determine vesting periods for all options granted under the Plan, and allows option terms to be up to ten years from the original grant date. Employees’ incentive stock options must vest at a minimum rate of 20% per year over a five year period, commencing on the date of grant. Most vest ratably over four years commencing on the date of the option grant. In the case of directors, such options are granted annually and they expire ten years after the date of their grant and vest ratably, on a monthly basis, over the next 12 months. Non-employee directors have vesting of 50% immediately on grant and the balance vest ratably, on a monthly basis, over the next 12 months. Advisors or consultants can have vesting range from 100 percent of the option grants vesting immediately to ratably, on a monthly basis, up to 48 months.
	The following table summarizes stock option activity for the years ended December 31, 2013 and 2012:
				Weighted
		Number of		Average				Exercise Price
		Shares		Exercise Price				Range
	Outstanding at December 31, 2011	267,856		$	8.87		$	0.46	–	$	17.5
	Granted	—		$	—		$				—
	Exercised	—		$	—		$				—
	Expired or Forfeited	-75,127		$	0.65		$	0.46	–	$	2.17
	Outstanding at December 31, 2012	192,729		$	10.68		$	1.71	–	$	17.5
	Granted	45,000		$	2		$				2
	Exercised	—		$	—		$				—
	Expired or Forfeited	-23,211		$	2.71		$	1.94	–	$	17.5
	Outstanding at December 31, 2013	214,518		$	9.72		$	1.71	–	$	17.5
	As of December 31, 2013, there were 200,387 options that were fully vested and exercisable at weighted average exercise price of $9.71 per share. The weighted average remaining contractual term on the vested options is 5.6 years.
	The unvested balance of 14,131 options as of December 31, 2013, are exercisable at a weighted average exercise price of $9.91 per share. The weighted average remaining contractual term on the vested options is 6.6 years.
	The following tables summarize stock option information at December 31, 2013:
	Total Options Outstanding
						Weighted		Weighted
						average		average
	Range of exercise price		Shares			remaining life (yrs)		exercise price
	$1.71 to $2.00		57,723			7.6		$	1.94
	$7.50 to $11.25		102,637			6.6		$	10.67
	$15.00 to $17.50		54,158			3.6		$	16.23
			214,518			6.1		$	9.72
	Exercisable Options Outstanding
						Weighted		Weighted
						average		average
						remaining life
	Range of exercise price		Shares			(yrs)		exercise price
	$1.71 to $2.00		57,723			7.6		$	1.93
	$7.50 to $11.25		88,506			5.6		$	10.78
	$15.00 to 17.50		54,158			3.6		$	16.22
			200,387			5.6		$	9.71
	Unvested Options Outstanding
				Weighted		Weighted
				average		average
				remaining life
	Range of exercise price	Shares		(yrs)		exercise price
	$1.71 to $2.00	—		—		$	—
	$7.50 to $11.25	14,131		6.6		$	9.91
	$15.00 to $17.50	—		—		$	—
		14,131		6.6		$	9.91
	The weighted average exercise price of options granted during 2013 was $2.00 with an aggregate value of $81,884.
	There were no options granted in 2012.
	Cash received from option exercises in 2013 and 2012, amounted to $-0- and $-0-, respectively. All of the shares issued out of common stock.
	With respect to any non-qualified stock options and incentive stock options that are exercised and held for less than one year, the Company recognizes a tax benefit upon exercise in an amount equal to the tax effect of the difference between the option price and the fair market value of the common stock on the exercise date.
	The table below summarizes the impact of outstanding stock options on the results of operations for the years ended December 31, 2013 and 2012:
	December 31,	2013			2012
	Stock-Based Compensation Expense:
	Stock Options	$	159,272		$	172,233
	Income Tax Benefit		—			—
	Net Decrease in Net Income	$	159,272		$	172,233
	Decrease in Earnings Per Share:
	Basic	$	0.027		$	0.049
	Diluted	$	0.027		$	0.048
	The Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards under FASB ASC Topic 718. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and expected volatility. For valuation purposes, stock option awards were categorized into two groups, stock option grants to employees and stock option grants to members of the Board of Directors.
The expected term of options granted was estimated to be the average of the vesting term, historical exercise and forfeiture rates, and the contractual life of the option. The expected volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted. The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. Cash dividends have never been paid and are not anticipated to be paid in the foreseeable future. Therefore, the assumed expected dividend yield is zero.
The following summary table shows the assumptions used to compute the fair value of stock options granted during 2013 and 2012 and their estimated value:
December 31,	2013				2012
Assumptions for Black-Scholes:
Expected term in years		10				—
Volatility		128.8	%			—
Risk-free interest rate		2.81	%			—
Expected annual dividends		None				None
Value of options granted:
Number of options granted		45,000				—
Weighted average fair value/share	$	2			$	N/A
Fair value of options granted	$	81,884			$	N/A
FASB ASC Topic 718 requires pre-vesting option forfeitures at the time of grant to be estimated and periodically revised in subsequent periods if actual forfeitures differ from those estimates. Stock-based compensation expense is recorded only for those awards expected to vest using an estimated forfeiture rate based on historical pre-vesting forfeiture data.
Unrecognized stock-based compensation expense was approximately $89,217 as of December 31, 2013, relating to a total of 14,131 unvested stock options under the Company’s stock option plans. This stock-based compensation expense is expected to be recognized over a weighted average period of approximately 1.1 years.

Commitments

Commitments	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments	'
	Note 25 — Commitments
	The Company leases office and manufacturing space under operating leases that expires on September 30, 2014. It requires monthly payments of $4,200 plus insurance, taxes and common charges.
	Rent expense for the years ended December 31, 2013 and 2012 totaled $104,766 and $176,830, respectively.
	Future minimum payments required under operating lease obligations as of December 31, 2013 were as follows:
				Total Minimum
		2014		Lease Payments
		$	45,670	$	45,670
	For the lease agreements described above, the Company is required to pay the pro rata share of the real property taxes and assessments, expenses and other charges associated with these facilities.

Employee_Benefit_Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Employee Benefit Plans	'
	Note 26 — Employee Benefit Plans
	The Company has a Section 401(k) Savings Plan which covers employees who meet certain age and length of service requirements. To date the plan is comprised of 100% employee deferrals.

Litigation

Litigation	12 Months Ended
	Dec. 31, 2013
Litigation Disclosure [Abstract]	'
Litigation	'
	Note 27 — Litigation
	We are not currently involved in any pending legal proceeding or litigation.

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2013
Risks and Uncertainties [Abstract]	'
Concentrations	'
	Note 28 — Concentrations
	For 2013 and 2012, one customer accounted for approximately -0-% and 10% of sales, respectively. The sales to this customer were part of the discontinued operations referred to in Note 4. Sales to the U.S. government accounted for approximately 17% and 11%, respectively. Portions of these government sales were part of discontinued operations.
	Accounts receivable from the U.S. government accounted for 79%, and 0% of accounts receivable at December 31, 2013 and 2012, respectively.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	Note 29 — Related Party Transactions
	During 2013, $-0- and $ 199,476 of revenues and purchases, respectively were derived from a minority stockholder (less than 5%) of the Company who also represented $-0- of the accounts receivable balance and $90,818 of the accounts payable balance at December 31, 2013.
	During 2012, $550,498 and $ 274,373 of revenues and purchases, respectively were derived from a minority stockholder (less than 5%) of the Company who also represented $-0- of the accounts receivable balance and $66,000 of the accounts payable balance at December 31, 2012, $361,910 of the Long Term Portion of Deferred Trade Payable balance and $120,637 of the Current Portion of Deferred Trade Payables. All of these revenues were reported as discontinued operations.
	Included in long-term debt as of December 31, 2012 and during half of 2013 were two notes payable to an officer of the Company. Pursuant to a debt conversion agreement, in connection with the closing of the public offering on August 5, 2013, these note amounts plus accrued interest were converted into shares of common stock based on the offering price of $2.00 per share and warrants exercisable at $2.25 per share. Interest expense related to the note payable amounted to $32,507 for the period it was outstanding in 2013 and $32,507 for the years ended December 31, 2012. Total accrued interest on the note payable was $213,795 as of December 31, 2012. See Note 14 and 19 for details.
	The Company has accrued compensation owed to two officers of the Company. On March 27, 2013, the Company entered into a deferred compensation deferral and conversion option agreements with these two officers, which agreements were subject to the closing of the Company’s public stock offering and which agreements were effective upon such closing on August 5, 2013. Pursuant to those agreements the officers converted in connection with the closing of the public offering on August 5, 2013 a total of $1,126,763 of their deferred compensation amounts plus accrued interest totaling $515,806 into shares of the Company’s common stock based on the offering price of $2.00 per share and warrants exercisable at $2.25 per share. See Note 19 for details. Interest expense related to accrued current and long-term accrued compensation amounts to $107,209 and $107,209 for the years ended December 31, 2013 and 2012, respectively. Total current and long-term accrued interest on the accrued compensation was $-0- as of December 31, 2013 and $446,532 as of December 31, 2012. See Note 18 for details.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Operations	'
	Operations
	Vuzix Corporation (the Company) was formed in 1997 under the laws of the State of Delaware and maintains its corporate offices in Rochester, New York. The Company is engaged in the design, manufacture, marketing and sale of devices that are worn like eyeglasses and which feature built-in video screens that enable the user to view video and digital content, such as movies, computer data, the Internet or video games. Our products (known commercially as “Video Eyewear”) are used to view high resolution video and digital information from portable devices, such as cell phones, portable media players, gaming systems and laptop computers and from personal computers. Our products provide the user with a virtual viewing experience that emulates viewing a large screen television or desktop computer monitor practically anywhere, anytime.
Principles of Consolidation	'
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Vuzix Europe and Vuzix Finland, OY. All significant inter-company transactions have been eliminated.
Segment Data, Geographic Information and Significant Customers	'
	Segment Data, Geographic Information and Significant Customers
	The Company is not organized by market and is managed and operated as one business. A single management team that reports to the chief operating decision maker comprehensively manages the entire business. The Company does not operate any material separate lines of business or separate business entities. Accordingly, the Company does not accumulate discrete information, other than product revenue and material costs, with respect to separate product lines and does not have separately reportable segments as defined by FASB ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information,”
	Shipments to customers outside of the United States approximated 36% and 27% of sales in 2013 and 2012, respectively. No single international country represented more than 10% of revenues. The Company does not maintain significant amounts of long-lived assets outside of the United States other than tooling held by its third party manufacturers, primarily in China.
	The Company has at times had a concentration of sales to the U.S. government, the majority of which was reported as discontinued operations and they amounted to approximately 17% and 11% of sales in 2013 and 2012, respectively. Accounts receivable from the U.S. government accounted for 79% and -0-% of accounts receivable at December 31, 2013 and 2012, respectively. Another customer, who is also a minority stockholder, represented -0-% and 10% of our total revenues, all of which was reported as sales from discontinued operations in 2012.
Foreign Currency Transactions	'
	Foreign Currency Transactions
	The U.S. dollar is the functional currency of the Company’s foreign subsidiaries. Gains and losses arising upon settlement of foreign currency denominated transactions or balances are included in the determination of income.
Use of Estimates	'
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at year end and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Concentration of Credit Risk	'
	Concentration of Credit Risk
	The Company performs ongoing credit evaluations of its customers’ financial condition and maintains an allowance for uncollectible accounts receivable based upon the expected collectability of all accounts receivable.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company’s cash received is applied against its revolving line of credit on a periodic basis based on projected monthly cash flows, reducing interest expense. Cash and cash equivalents can include highly liquid investments with original maturities of three months or less.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company’s financial instruments primarily consists of cash and cash equivalents, accounts receivable, inventories, prepaid expenses and other assets, accounts payable, lines of credit, current portion of long-term debt and capital leases, customer deposits, accrued expenses, and income taxes payable.
	As of the consolidated balance sheet date, the estimated fair values of the financial instruments were not materially different from their carrying values as presented due to the short maturities of these instruments and that the interest rates on the borrowing approximate those that would have been available for loans for similar remaining maturity and risk profiles at respective year ends.
Allowance for Doubtful Accounts	'
	Allowance for Doubtful Accounts
	The Company establishes an allowance for uncollectible trade accounts receivable based on the age of outstanding invoices and management’s evaluation of collectability of outstanding balances. These provisions are established when the aging of outstanding amounts exceeds allowable terms and are re-evaluated at each quarter end for adequacy. In determining the adequacy of the provision, the Company considers known uncollectible or at risk receivables.
Provision for Future Warranty Costs	'
	Provision for Future Warranty Costs
	Warranty costs are accrued, to the extent that they are not recoverable from third party manufacturers, for the estimated cost to repair or replace products for the balance of the warranty periods. The Company’s products are covered by standard warranty plans that extend normally 12 months to 24 months from the date of product shipment. The Company provides for the costs of expected future warranty claims at the time of product shipment or over-builds to cover replacements. The adequacy of the provision is assessed at each quarter end and is based on historical experience of warranty claims and costs.
Inventories	'
	Inventories
	Inventories are valued at the lower of cost, or market using the first-in, first-out method. The Company does include direct overhead costs in its inventory valuation costing. The Company records provisions for excess, obsolete or slow moving inventory based on changes in customer demand, technology developments or other economic factors. The Company’s products have product life cycles that range on average from two to three years currently. At both the product introduction and product discontinuation stage, there is a higher degree of risk of inventory obsolescence. The provision for obsolete and excess inventory is evaluated for adequacy at each quarter end. The estimate of the provision for obsolete and excess inventory is partially based on expected future product sales, which are difficult to forecast for certain products.
Revenue Recognition	'
	Revenue Recognition
	The Company recognizes revenue from product sales in accordance with FASB ASC Topic 605 “Revenue Recognition”. Product sales represent the majority of the Company’s revenue. The Company recognizes revenue from these product sales when persuasive evidence of an arrangement exists, delivery has occurred or services have been provided, the sale price is fixed or determinable, and collectability is reasonably assured. Additionally, the Company sells its products on terms which transfer title and risk of loss at a specified location, typically shipping point. Accordingly, revenue recognition from product sales occurs when all factors are met, including transfer of title and risk of loss, which typically occurs upon shipment by the Company. If these conditions are not met, the Company will defer revenue recognition until such time as these conditions have been satisfied. The Company collects and remits sales taxes in certain jurisdictions and reports revenue net of any associated sales taxes. The Company also sells certain products through distributors who are granted limited rights of return for stock balancing against purchases made within a prior 90 day period, including price adjustments downwards that the Company implements on any existing inventory. The provision for product returns and price adjustments is assessed for adequacy both at the time of sale and at each quarter end and is based on recent historical experience and known customer claims.
	Revenue from any engineering consulting and other services is recognized at the time the services are rendered. The Company accounts for its longer-term development contracts, which to date have all been firm fixed-priced contracts, on the percentage-of-completion method, whereby income is recognized as work on contracts progresses, but estimated losses on contracts in progress are charged to operations immediately. The percentage-of-completion is determined using the cost-to-cost method. Amounts are generally billed on a monthly basis. To date all such contracts have been less than one calendar year in duration.
	The Company recognizes software license revenue under ASC 985-605 “Software Revenue Recognition” and under ASC 605-25 “Revenue Arrangements with Multiple Deliverables”, and related interpretations, as amended. Licensed software may be sold as a stand-alone element, with other software elements, or in conjunction with hardware products. When the Company’s products consists of more than one element, it is considered to be a multiple element arrangement (MEA). When sold as a stand-alone element, the revenue is recognized upon shipment as discussed above. When sold as part of a MEA, revenue from the licensed software is recognized when the product and embedded software is shipped to the customer.
	For either a single element transaction or a MEA, the Company allocates consideration to all deliverables based on their relative stand-alone selling prices. Amendments to ASC 605-25, which became effective January 1, 2011, establish a hierarchy to determine the stand-alone selling price as follows:
		•	Vendor Specific Objective Evidence of the fair value (VSOE),
		•	Third Party Evidence (TPE)
		•	Best Estimate of the Selling Price (ESP)
	Sales which constitute a MEA are accounted for by determining if the elements can be accounted for as separate accounting units, and if so, by applying values to those units, per the hierarchy above. If VSOE is not available, management estimates the fair selling price using historical pricing for similar items, in conjunction with current pricing and discount policies.
	Revenue from licensed software is recognized upon shipment and in accordance with industry-specific software recognition accounting guidance. Software updates that will be provided free of charge are evaluated on a case-by-case basis to determine whether they meet the definition of an upgrade and create a multiple element arrangement. The consideration allocated to the unspecified software upgrade rights and non-software services is deferred and recognized rateably over the 24-month estimated life of the devices. The Company’s BESP for the unspecified software upgrade right and non-software services is $25 per unit for the M100 Smart Glass.
	Fees charged to customers for post-contract Technical Support are recognized ratably over the term of the contract. Costs related to maintenance obligations are expensed as incurred.
Tooling and Equipment	'
	Tooling and Equipment
	Tooling and equipment are stated at cost. Depreciation of tooling and equipment is provided for using the straight-line method over the following estimated useful lives:
	Computers and Software	3 years
	Manufacturing Equipment	5 years
	Tooling	3 years
	Furniture and Equipment	5 years
	Repairs and maintenance costs are expensed as incurred. Asset betterments are capitalized.
Patents and Trademarks	'
	Patents and Trademarks
	The Company capitalizes the costs of obtaining its patents and registration of Trademarks. Such costs are accumulated and capitalized during the filing periods, which can take several years to complete. Successful applications that result in the granting of a patent or trademark are then amortized over 15 years on a straight-line basis. Unsuccessful applications are written off and expensed in the fiscal period where the application is abandoned or discontinued.
Software Development Costs	'
	Software Development Costs
	The Company capitalizes the costs of obtaining its software once technological feasibility has been determined by management. Such costs are accumulated and capitalized and projects can take several years to complete. Unsuccessful or discontinued software projects are written off and expensed in the fiscal period where the application is abandoned or discontinued. Costs incurred internally in researching and developing a computer software product are charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. Generally, this occurs shortly before the products are released to manufacturing. The amortization of these costs is included in cost of revenue over the estimated life of the products, which currently is estimated as 3 years using a straight-line basis.
Long-Lived Assets	'
	Long-Lived Assets
	The Company regularly assesses all of its long-lived assets for impairment when events or circumstances indicate their carrying amounts may not be recoverable, in accordance with FASB ASC Topic 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets.” In 2013, an impairment charge of $73,423 was recorded related to abandoned patents and trademarks. In 2012, an impairment charge of $64,703 was recorded related to abandoned patents and trademarks.
Research and Development	'
	Research and Development
	Research and development costs, are expensed as incurred consistent with the guidance of FASB ASC Topic 730, “Research and Development,” and include employee related costs, office expenses, third party design and engineering services, and new product prototyping costs. Costs incurred internally in researching and developing a computer software product are charged to expense until technological feasibility has been established for the product.
Shipping and Handling Costs	'
	Shipping and Handling Costs
	Amounts charged to customers and costs incurred by the Company related to shipping and handling are included in net sales and cost of goods sold, respectively, in accordance with FASB ASC Topic 605-45, “Revenue Recognition – Principal Agent Consideration”, “Accounting for Shipping and Handling Fees and Costs.”
Advertising	'
	Advertising
	Advertising costs are expensed as incurred and recorded in “Selling and Marketing” in the Consolidated Statements of Operations. Advertising expense for the years ended December 31, 2013 and 2012 amounted to $231,552 and $253,815, respectively. These amounts are inclusive of $4,500 in 2012 that are included in Discontinued Operations.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes in accordance with FASB ASC Topic 740-10, “Income Taxes.” Accordingly, the Company provides deferred income tax assets and liabilities based on the estimated future tax effects of differences between the financial and tax bases of assets and liabilities based on currently enacted tax laws. A valuation allowance is established for deferred tax assets in amounts for which realization is not considered more likely than not to occur.
Earnings Per Share	'
	Earnings Per Share
	Basic earnings per share is computed by dividing the net (loss) income less accrued dividends on any outstanding preferred stock by the weighted average number of common shares outstanding for the period. Diluted earnings per share calculations reflect the assumed exercise of all dilutive employee stock options and warrants applying the treasury stock method promulgated by FASB ASC Topic 260, “Earnings Per Share” and the conversion of any outstanding convertible preferred shares or notes payable that are-in-the-money, applying the as-if-converted method. However, if the assumed exercise of stock options and warrants and the conversion of any preferred shares or convertible notes payable are anti-dilutive, basic and diluted earnings per share are the same for all periods.
Stock-Based Employee Compensation	'
	Stock-Based Employee Compensation
	The Company accounts for share-based compensation to employees and directors in accordance with FASB ASC Topic 718 “Compensation Stock Expense,” which requires that compensation expense be recognized in the consolidated financial statements for share-based awards based on the grant-date fair value using a Black-Scholes valuation model of those awards. The Company uses the fair market value of our common stock on the date of each option grant based on market price of the Company’s common shares on the TSX Venture Exchange and since August 5, 2013 on the OTCQB. Stock-based compensation expense includes an estimate of forfeitures and is recognized over the requisite service periods of the awards on a straight-line or graded vesting basis, which is generally commensurate with the vesting term. As a result of the adoption of FASB ASC Topic 718, stock-based compensation expense associated with stock option grants for the years ending December 31, 2013 and 2012 was $159,272 and $172,233, respectively.
	The Company issues new shares upon stock option exercises. Please refer to Note 22, Stock Option Plans, for further information.
Derivative Liability and Fair Value Measurements	'
	Derivative Liability and Fair Value Measurements
	The Company has adopted the provisions of FASB ASC Topic 820, “Fair Value Measurements and Disclosures as of January 1, 2008 for financial instruments. This standard defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820 permits an entity to measure certain financial assets and financial liabilities at fair value with changes in fair value recognized in earnings each period. In accordance with ASC 815-10-25, we measured the derivative liability using a Lattice pricing model at their issuance date and subsequently they are remeasured. Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value. Derivatives that have more than one year remaining in their life are shown as long term derivative liabilities.
	ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value. Level 1 inputs are quoted prices in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are directly or indirectly observable for the asset or liability. Such inputs include quoted prices in active markets for similar assets and liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, or inputs derived principally from or corroborated by observable market data by correlation or other means. Level 3 inputs are unobservable inputs for the asset or liability. Such inputs are used to measure fair value when observable inputs are not available.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	In December 2011, the FASB issued new guidance which requires enhanced disclosures on offsetting amounts within the balance sheet, including disclosing gross and net information about instruments and transactions eligible for offset or subject to a master netting or similar agreement. The guidance is effective for the company beginning January 1, 2013 and is to be applied retrospectively. The adoption of this guidance, which is related to disclosure only, did not have an impact on the company’s consolidated financial position, results of operations or cash flows.
	There are no other recent accounting pronouncements that are expected to have a material impact on the consolidated financial statements.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Schedule of Property and Equipment Estimated Useful Life	'
	Tooling and equipment are stated at cost. Depreciation of tooling and equipment is provided for using the straight-line method over the following estimated useful lives:
	Computers and Software	3 years
	Manufacturing Equipment	5 years
	Tooling	3 years
	Furniture and Equipment	5 years

Discontinued_Operations_Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2013
Discontinued Operations and Disposal Groups [Abstract]	'
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement	'
	Below is a summary of these results:
		For Years
		Ended December 31,
		2013		2012
	Sales of Products	$	—	$	1,768,754
	Sales of Engineering Services		—		358,921
	Total Sales		—		2,127,675
	Total Cost of Sales		—		1,273,907
	Gross Profit		—		853,768
	Operating Expenses:
	Research and Development		—		295,138
	Selling and Marketing		—		200,378
	General and Administrative		—		—
	Depreciation and Amortization		—		—
	Interest Expense on Senior Debt*		—		353,584
	Amortization Senior Debt Discount*		—		752,248
	Income (Loss) from Discontinued Operations		—		-747,580
	Gain (Loss) on Disposal of Discontinued Operations		—		5,837,607
	Provision (Benefit) for Income Taxes (Note 21)		—		19,800
			—		5,817,807
	Net Income (Loss) from Discontinued Operations	$	—	$	5,070,227
	Basic Income (Loss) per Share	$	—	$	1.43
	Diluted Income (Loss) per Share	$	—	$	1.43
	Weighted-average Shares Outstanding Basic (Note 6)		—		3,536,865
	Weighted-average Shares Outstanding Diluted (Note 6)		—		3,651,100
	* Amounts reported represent the interest expense and the amortization of the discount on the Senior Term debt that was required to be repaid from the proceeds of the TDG Asset sale.

Gain_on_Asset_Disposal_Tables

Gain on Asset Disposal (Tables)	12 Months Ended
	Dec. 31, 2013
Gain (Loss) On Disposition Of Assets [Abstract]	'
Schedule of Major Components of Reported Gain on Sale	'
	The following represents the major components of the reported gain on sale:
	Net Sales Price	$	8,345,793
	Less:
	Professional Fees on Sale of Assets		-825,596
	Accounts Receivable Sold		-299,599
	Inventories Sold		-1,135,042
	Tooling & Equipment Sold		-120,832
	Patents and Trademarks Sold		-113,117
	Federal Income Tax		-19,800
	Sales Taxes on Asset Sale		-14,000
	Net Gain on Sale of Asset	$	5,817,807

Net_Earnings_Loss_Per_Share_EP1

Net Earnings (Loss) Per Share (EPS) (Tables)	12 Months Ended
	Dec. 31, 2013
Earnings (Loss) Per Share	'
Schedule of Earnings Per Share, Basic and Diluted	'
	For periods of net loss, basic and diluted EPS are the same as the assumed exercise of stock options and warrants and the conversion of convertible debt are anti-dilutive.
			Year Ended December 31,
			2013		2012
	Net (Loss) from Continuing Operations (A)		$	-10,146,228	$	-4,747,387
	Net Income (Loss) (B)		$	-10,146,228	$	322,840
	Add - Interest savings from converted debt			—		114,537
	Adjusted Diluted Net Income (Loss) (F)		$	-10,146,228	$	437,377
	Weighted Average Shares Outstanding:
	Weighted average basic shares outstanding (C)			5,988,595		3,536,865
	Dilutive effect of options and warrants			2,984,199		31,354
	Dilutive effect of convertible debt			-		82,881
	Weighted Average Dilutive Shares Outstanding (D)			8,972,794		3,651,100
	Earnings (Loss) Per Share From Continuing Operations
	Basic (A/C)		$	-1.69	$	-1.34
	Diluted (1) (2)		$	-1.69	$	-1.34
	Earnings (Loss) Per Share
	Basic (B/C)		$	-1.69	$	0.09
	Diluted (F/D) (1)		$	-1.69	$	0.09
		-1	Due to net loss for period, dilutive loss per share is the same as basic.
		-2	Due to the antidilutive impact of the convertible debt under the if-converted method, the diluted earnings per share is the same as basic.

Accounts_Receivable_Net_Tables

Accounts Receivable, Net (Tables)	12 Months Ended
	Dec. 31, 2013
Accounts Receivable, Net [Abstract]	'
Schedule of Accounts Receivable	'
	Accounts receivable consisted of the following:
		December 31,		December 31,
		2013		2012
	Accounts Receivable	$	214,920	$	170,600
	Less: Allowance for Doubtful Accounts		—		—
	Net	$	214,920	$	170,600

Inventories_Net_Tables

Inventories, Net (Tables)	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
Schedule of Inventories	'
	Inventories consisted of the following:
		December 31,		December, 31,
		2013		2012
	Purchased Parts and Components	$	1,094,250	$	945,550
	Work in Process		153,065		46,259
	Finished Goods		280,279		259,112
	Less: Reserve for Obsolescence		-573,967		-563,740
	Net	$	953,627	$	687,181

Deferred_Offering_Costs_Tables

Deferred Offering Costs (Tables)	12 Months Ended
	Dec. 31, 2013
Deferred Offering Costs Disclosure [Abstract]	'
Deferred Offering Costs	'
	Deferred offering costs consist principally of legal, accounting and underwriters’ fees incurred related to the public offering of the Company’s common stock and warrants as discussed in Note 3, which were charged to capital as of the completion of the offering  on August 5, 2013.
		December 31,		December 31,
		2013		2012
	Professional and agents’ fees paid	$	—	$	57,500
	Professional and agents’ fees included Accrued Expenses		—		142,071
	Total	$	—	$	199,571

Tooling_and_Equipment_Net_Tabl

Tooling and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment, Net [Abstract]	'
Property, Plant and Equipment	'
	Tooling and equipment consisted of the following:
		December 31,		December 31,
		2013		2012
	Tooling and Manufacturing Equipment	$	1,748,006	$	1,685,006
	Computers and Software		645,429		615,567
	Furniture and Equipment		749,233		763,134
		$	3,142,668	$	3,063,707
	Less: Accumulated Depreciation		-2,696,339		-2,398,740
	Net	$	446,329	$	664,967

Patents_and_Trademarks_Net_Tab

Patents and Trademarks, Net (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Finite-Lived Intangible Assets	'
		December 31,		December 31,
		2013		2012
	Patents and Trademarks	$	777,593	$	803,687
	Less: Accumulated Amortization		-281,985		-252,380
	Net	$	495,608	$	551,307

Software_Development_Costs_Tab

Software Development Costs (Tables)	12 Months Ended
	Dec. 31, 2013
Research and Development [Abstract]	'
Schedule Of Software Development Costs	'
		December 31,		December 31,
		2013		2012
	Software Development Costs	$	240,561	$	—
	Less: Accumulated Amortization		—		—
	Net	$	240,561	$	—

Notes_Payable_Tables

Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2013
Notes Payable [Abstract]	'
Notes payable represent promissory notes payable	'
		December 31,		December 31,
		2013		2012
	Note payable to officers and shareholders of the Company. Principal along with accrued interest is payable on demand and paid on December 31, 2014. The notes bear interest at 18.5% and secured by all the assets of the Company.	$	229,787	$	165,738
	Note payable secured by all the assets of Company and the guarantee of its President and CEO. The effective interest rate is 31%. The note is to be repaid in 12 blended monthly payments of $5,645.		37,383		46,737
	Note payable to an officer of the Company due on December 31, 2013. The note bears interest at 7.49% and monthly principal payments of $2,691 plus accrued interest are required. The note is secured by all the assets of the Company.		11,297		45,734
		$	278,467	$	258,209

Accrued_Expenses_Tables

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2013
Payables and Accruals [Abstract]	'
Components of Accrued Expenses	'
	Accrued expenses consisted of the following:
		December		December
		31, 2013		31, 2012
	Accrued Wages and Related Costs	$	91,385	$	31,197
	Accrued Compensation		360,670		181,322
	Accrued Professional Services		69,500		181,227
	Accrued Warranty Obligations		31,619		93,788
	Other Accrued Expenses		1,090		32,138
	Total	$	554,264	$	519,672
Changes in Accrued Warranty Obligations	'
	The changes in the Company’s accrued warranty obligations for the years ended December 31, 2013 and 2012 were as follows:
	Accrued Warranty Obligations at December 31, 2011	$	118,611
	Reductions for Settling Warranties		-126,308
	Warranty Issued During Year		101,485
	Accrued Warranty Obligations at December 31, 2012	$	93,788
	Reductions for Settling Warranties		-74,287
	Warranty Issued During Year		12,118
	Accrued Warranty Obligations at December 31, 2013	$	31,619

Derivative_Liability_and_Fair_1

Derivative Liability and Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Schedule Of Assets And Liabilities Measured At Fair Value On A Recurring Basis	'
	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 30, 2013:
		Total			(Level 1)			(Level 2)		Level (3)
	Assets	$	—		$	—		$	—	$	—
	Total assets measured at fair value		—			—			—		—
	Liabilities
	Derivative Liability		12,035,816			—			—		12,035,816
	Total liabilities measured at fair value (Long-Term)	$	12,035,816		$	—		$	—	$	12,035,816
Schedule of Fair Value Level 3 warrant liabilities	'
		December			December
		31, 2013			31, 2012
	Fair value – beginning of period	$	—		$	—
	Warrants issue		9,067,283			—
	Reclassification of warrant liabilities to Additional Paid-in Capital		-526,245			—
	Reclassification of warrant exercises to Additional Paid-in Capital		-80,500			—
	Change in fair value		3,575,278			—
	Fair value – end of period	$	12,035,816		$	—
Schedule Of Fair Value Of Warrants	'
	The following summary table shows the assumptions used to compute the fair value of the warrants granted during 2013 at issuance and as of December 31, 2013 is:
		December 31, 2013				At Issuance
	Assumptions for Pricing Model:
	Expected term in years		4.2 to 4.6				4.62 to 5.0
	Volatility range for years 1 to 5		56	%			61 to 110	%
	Risk-free interest rate		1.75	%			0.77 to 1.41	%
	Expected annual dividends		None				None
	Value of warrants issued:
	Fair value of warrants	$	12,035,816			$	9,067,283

Accrued_Compensation_Tables

Accrued Compensation (Tables)	12 Months Ended
	Dec. 31, 2013
Compensation Related Costs [Abstract]	'
Unpaid principal amounts are shown as Long-Term Liabilities	'
		Accrued		Accrued Interest
		Compensation
	Balance as at December 31, 2011	$	810,096	$	339,323
	Additions 2012		200,000		103,315
	Subtractions 2012		—		—
	Balance as at December 31, 2012		1,010,096		442,638
	Additions 2013		116,667		73,168
	Subtractions 2013		-1,126,763		-515,806
	Balance as at December 31, 2013	$	—	$	—

LongTerm_Debt_Tables

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Components of Long-Term Debt	'
	Long-term debt consisted of the following at December 31:
			December 31,			December
			2013			31, 2012
	Note payable to an officer of the Company. The principal was not subject to a fixed repayment schedule, bore interest at 8% per annum and was secured by all of the assets of the Company		$	—		$	209,208
	Note payable to an officer of the Company. The principal and interest was subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bore interest at 12% per annum and was secured by a subordinated position in all the assets of the Company.			—			225,719
	Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2012 over 48 months.			256,727			396,004
	The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.			-71,701			-97,003
	Convertible, Senior Secured Term Debt. The principal was to be repaid over 15 months, with equal payments of principal beginning on October 15, 2012. The Company did not make any of the required principal payments and was in default. The loan bore interest at 13.5%, per annum, which was payable monthly on the 15th of each month. The loan was secured by a first security position in all the Intellectual Property assets of the Company and a security interest in all of the other assets of the Company that was subordinate only to the security interest that secures the Company’s working capital loan.			—			619,122
	Long-term secured deferred trade payable for which the principal and interest was subject to a fixed blended repayment schedule of 24 and 36 months, commencing July 15, 2013. The deferred trade payable bears interest at 12% per annum and was secured by a subordinated position in all the assets of the Company.			—			1,320,643
	Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per annum and is secured by a subordinated position in all the assets of the Company.			84,790			101,748
			$	269,816		$	2,775,441
	Less: Amount Due Within One Year			-99,320			-1,060,188
	Amount Due After One Year		$	170,496		$	1,715,253
Aggregate maturities for all long-term borrowings	'
	The aggregate maturities reflect future cash principle payments exclusive of non-cash amortization discount for all long-term borrowings as of December 31, 2013 are as follows:
	2014			2015			2016		2017		Thereafter		Total
	$	99,320		$	100,064		$	70,432	$	—	$	—	$	269,816

Capital_Lease_Obligations_Tabl

Capital Lease Obligations (Tables)	12 Months Ended
	Dec. 31, 2013
Capital Lease Obligations [Abstract]	'
Capital lease obligation payments	'
	The related equipment is collateral to the leases. Final payments are due through September 2015.
		December 31,		December 31,
		2013		2012
	Total Principal Payments	$	41,552	$	97,285
	Less: Amount Due Within One Year		-24,670		-57,244
	Amount Due After One Year	$	16,882	$	40,041
Annual requirements for retirement of the capital lease obligations	'
	Annual requirements for retirement of the capital lease obligations are as follows:
	December 31,	Amount
	2014	$	31,687
	2015		18,445
	Total Minimum Lease Payments	$	50,132
	Less: Amount Representing Interest		-8,580
	Present Value of Minimum Lease Payments	$	41,552
Summary of assets held under capital leases	'
	The following is a summary of assets held under capital leases:
	December 31,	2013		2012
	Computers and Software	$	30,692	$	96,925
	Furniture and Equipment		35,083		92,446
		$	65,775		189,371
	Less: Accumulated Depreciation		-52,275		-81,190
	Net	$	13,500	$	108,181

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule Of Pre Tax Earnings	'
	Pre-tax earnings consisted of the following for the years ended December 31, 2013 and 2012:
	December 31,	2013			2012
	Total Pre-Tax (Loss) Earnings	$	-10,146,228		$	382,838
Schedule of Components of Income Tax Expense (Benefit)	'
	The provision (benefit) for income taxes for the years ended December 31, 2013 and 2012 was as follows:
		2013			2012
	Current Income Tax Provision (Benefit)
	Federal – (all related to Gain on Sale of Discontinued Operations)	$	—		$	19,800
	State and Foreign		—			—
	State Tax Credit Refund		—			—
	Net Change in Liability for Unrecognized Tax Benefits		—			—
		$	—		$	19,800
	Deferred Provision (Benefit)		—			—
	Total Provision (Benefit)	$	—		$	19,800
Schedule of Effective Income Tax Rate Reconciliation	'
	A reconciliation of the statutory U.S. federal income tax rate to the effective rates for the years ended December 31, 2013 and 2012 is as follows:
		2013				2012
	Federal Income Tax at Statutory Rate		34.4	%			34	%
	State Tax Provision, Net of Federal Benefit		0.5	%			3.5	%
	Foreign Income Taxed at Other Than 34%		-0.2	%			0	%
	Meals and Entertainment		0	%			1.4	%
	Stock Compensation Expense		-0.6	%			16.1	%
	Research and Development Credits		-0.2	%			4.2	%
	Loss on Derivative Valuation		-12.2	%			0	%
	Debt Discount		-0.2	%			0	%
	Officer’s Life Insurance		0	%			0.3	%
	Change in Rate Assumptions		41	%			-114.5	%
	Adjustments to Prior Year Tax Credits		0.7	%			-11.6	%
	Effective Tax Rate		63.2	%			-66.6	%
	Change in Valuations Allowance		-63.2	%			77.7	%
	Net Effective Tax Rate		0	%			11.1	%
Schedule of Deferred Tax Assets and Liabilities	'
	Deferred tax assets (liabilities) for the years ended December 31, 2013 and 2012 consist of the following:
		2013			2012
	Inventory and Inventory Related Items	$	196,871		$	234,000
	Warranty Reserves		10,845			32,000
	Accrued Interest		9,673			152,000
	Accrued Services		-1,887			28,000
	Accrued Loss Contingency		—			9,000
	Accrued Officer Compensation		111,276			—
	Net Operating Loss Carryforwards		9,739,496			2,881,000
	Accrued Compensation		—			405,000
	Amortization		-143,364			—
	(Gain)Loss on Fixed Assets		100,464			—
	Patents Costs and Loss on Abandonment or Sale of Patents		-81,093			—
	Charitable Contributions		2,487			—
	Unrealized Gains/Losses		47,049			—
	Tax Credit Carryforwards		1,466,429			1,399,000
	Depreciation		7,832			11,000
	Total Gross Deferred Tax	$	11,466,078		$	5,151,000
	Valuation Allowance — 100%		-11,466,078			-5,151,000
	Net Deferred Tax	$	—		$	—

Stock_Warrants_Tables

Stock Warrants (Tables)	12 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Changes in Warrants	'
	The following table shows the various changes in warrants for the years December 31, 2013 and 2012. A total of 6,551,654 warrants were issued during in 2013, with an aggregate fair value of $9,067,283, see Note 17 for further details. A total of 206,420 warrants were re-priced to $2.25 from $4.72 and 38,168 warrants were re-priced to $2.25 from $5.24 upon the closing of the public offering on August 5, 2013.
		December 31,		December 31,
		2013		2012
	Warrants Outstanding, Beginning of Year		656,641		867,628
	Exercised During the Year		-59,300		—
	Issued During the Year		6,551,654		—
	Forfeited During the Year		-1,220		-210,987
	Warrants Outstanding, End of Year		7,147,775		656,641

Stock_Option_Plans_Tables

Stock Option Plans (Tables)	12 Months Ended
	Dec. 31, 2013
Stock Option Plans [Abstract]	'
Stock option plans	'
	The exercise price per share subject to an option is determined by the administrator, but in the case of an ISO must not be less than the fair market value of a share of our common stock on the date of grant and in the case of a non-statutory stock option must not be less than 100% of the fair market value of a share of our common stock on the date of grant.
		2007 Plan		2009 Plan		Total
	Outstanding as of December 31, 2013	79,009		135,509		214,518
	Available for future issuance under plan	—		342,420		342,420
	Totals authorized by plan	79,009		477,929		556,938
Summary of Stock Option Activity	'
	The following table summarizes stock option activity for the years ended December 31, 2013 and 2012:
				Weighted
		Number of		Average				Exercise Price
		Shares		Exercise Price				Range
	Outstanding at December 31, 2011	267,856		$	8.87		$	0.46	–	$	17.5
	Granted	—		$	—		$				—
	Exercised	—		$	—		$				—
	Expired or Forfeited	-75,127		$	0.65		$	0.46	–	$	2.17
	Outstanding at December 31, 2012	192,729		$	10.68		$	1.71	–	$	17.5
	Granted	45,000		$	2		$				2
	Exercised	—		$	—		$				—
	Expired or Forfeited	-23,211		$	2.71		$	1.94	–	$	17.5
	Outstanding at December 31, 2013	214,518		$	9.72		$	1.71	–	$	17.5
Summary of stock option information	'
	The following tables summarize stock option information at December 31, 2013:
	Total Options Outstanding
						Weighted		Weighted
						average		average
	Range of exercise price		Shares			remaining life (yrs)		exercise price
	$1.71 to $2.00		57,723			7.6		$	1.94
	$7.50 to $11.25		102,637			6.6		$	10.67
	$15.00 to $17.50		54,158			3.6		$	16.23
			214,518			6.1		$	9.72
	Exercisable Options Outstanding
						Weighted		Weighted
						average		average
						remaining life
	Range of exercise price		Shares			(yrs)		exercise price
	$1.71 to $2.00		57,723			7.6		$	1.93
	$7.50 to $11.25		88,506			5.6		$	10.78
	$15.00 to 17.50		54,158			3.6		$	16.22
			200,387			5.6		$	9.71
	Unvested Options Outstanding
				Weighted		Weighted
				average		average
				remaining life
	Range of exercise price	Shares		(yrs)		exercise price
	$1.71 to $2.00	—		—		$	—
	$7.50 to $11.25	14,131		6.6		$	9.91
	$15.00 to $17.50	—		—		$	—
		14,131		6.6		$	9.91
Outstanding Stock Option on Result of Operation	'
	The table below summarizes the impact of outstanding stock options on the results of operations for the years ended December 31, 2013 and 2012:
	December 31,	2013			2012
	Stock-Based Compensation Expense:
	Stock Options	$	159,272		$	172,233
	Income Tax Benefit		—			—
	Net Decrease in Net Income	$	159,272		$	172,233
	Decrease in Earnings Per Share:
	Basic	$	0.027		$	0.049
	Diluted	$	0.027		$	0.048
Summary of assumptions used to compute the fair value of stock options granted	'
	The following summary table shows the assumptions used to compute the fair value of stock options granted during 2013 and 2012 and their estimated value:
	December 31,	2013				2012
	Assumptions for Black-Scholes:
	Expected term in years		10				—
	Volatility		128.8	%			—
	Risk-free interest rate		2.81	%			—
	Expected annual dividends		None				None
	Value of options granted:
	Number of options granted		45,000				—
	Weighted average fair value/share	$	2			$	N/A
	Fair value of options granted	$	81,884			$	N/A

Commitments_Tables

Commitments (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Contractual Payment Obligations for Operating Leases	'
	Future minimum payments required under operating lease obligations as of December 31, 2013 were as follows:
				Total Minimum
		2014		Lease Payments
		$	45,670	$	45,670

Basis_of_Presentation_Addition

Basis of Presentation (Additional Information (Detail)	12 Months Ended
	Dec. 31, 2013
Basis Of Presentation [Line Items]	'
Stockholders' Equity, Reverse Stock Split	'All per share amounts, outstanding shares, warrants, options and shares issuable pursuant to convertible securities for all periods reflect the Company’s 1-for-75 reverse stock split, which was effective February 6, 2013.

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Property Plant And Equipment Useful Life) (Detail)	12 Months Ended
	Dec. 31, 2013
Computers and Software	'
Property, Plant and Equipment, Estimated Useful Lives	'3 years
Manufacturing Equipment	'
Property, Plant and Equipment, Estimated Useful Lives	'5 years
Tooling	'
Property, Plant and Equipment, Estimated Useful Lives	'3 years
Furniture and Equipment	'
Property, Plant and Equipment, Estimated Useful Lives	'5 years

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Summary Of Significant Accounting Policies [Line Items]	'	'
Percentage Of Revenues From External Customers	36.00%	27.00%
Maximum Percentage Of Revenues From Foreign Countries	10.00%	'
Concentration Risk, Percentage	0.00%	10.00%
Percentage On Accounts Receivable	79.00%	0.00%
Advertising Expense	$231,552	$253,815
Stock Options	159,272	172,233
Asset Impairment Charges	73,423	64,703
Advertisement Expenses From Discontinued Operation	'	$4,500
M100 Smart Glass	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Best Selling Price Per Unit	25	'
Minimum	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Extended Product Warranty Period	'12 months	'
Finite-Lived Intangible Assets, Remaining Amortization Period	'3 years	'
Maximum	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Extended Product Warranty Period	'24 months	'
Trademarks and Patents	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Finite-Lived Intangible Assets, Remaining Amortization Period	'15 years	'
Minority Stockholder	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Concentration Risk, Percentage	17.00%	11.00%

Going_Concern_Issues_Additiona

Going Concern Issues (Additional Information) (Detail) (USD $)

0 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

Aug. 05, 2013

Dec. 31, 2013

Dec. 31, 2012

Jul. 15, 2013

Mar. 21, 2013

Aug. 05, 2013

Dec. 31, 2013

Jul. 15, 2013

Mar. 21, 2013

Dec. 31, 2013

Dec. 31, 2012

Aug. 05, 2013

Aug. 05, 2013

Other Offering Expenses [Member]

Officer

Convertible, Senior Secured Term Debt

Convertible, Senior Secured Term Debt

Convertible, Senior Secured Term Debt

Convertible, Senior Secured Term Debt

Common Stock And Warrants

Common Stock And Warrants

Officer

Commercial Loans [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Net (Loss) from Continuing Operations

'

($10,146,228)

($4,747,387)

'

'

'

'

'

'

'

'

'

'

Accumulated (Deficit)

'

-36,292,532

-26,146,304

'

'

'

'

'

'

'

'

'

'

Common Stock Shares Issued

4,025,000

9,600,453

3,536,865

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

4,025,000

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Price Per Share

2

'

'

'

'

'

'

'

'

'

'

'

'

Class Of Warrant Or Right Share Price Of Warrants Or Rights

0.0001

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights

2.25

'

'

'

'

'

'

'

'

'

'

'

'

Investment Warrants Expiration term

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds From Issuance Public Offering

8,050,000

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Amount

'

1,642,569

0

'

'

'

'

'

'

'

'

2,316,007

1,642,569

Debt Instrument, Convertible, Conversion Price

'

$2

'

'

'

'

'

'

'

'

'

$2

$2

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

16.00%

16.00%

'

7.49%

'

'

13.50%

13.50%

'

'

Proceeds From Sale Of Assets

'

0

7,520,197

'

'

'

'

'

'

'

'

'

'

Debt Instrument Repayment Penalty

'

'

'

'

'

'

'

40,000

160,000

'

'

'

'

Secured Long-term Debt, Noncurrent

'

'

'

'

'

'

'

200,000

800,000

'

'

'

'

Other Accrued Liabilities Current

'

$1,090

$32,138

'

'

$1,358,641

'

'

'

'

'

'

'

Discontinued_Operations_Schedu

Discontinued Operations (Schedule Of Disposal Groups Including Discontinued Operations Income Statement) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012
Total Sales	$0		$2,127,675
Total Cost of Sales	0		1,273,907
Gross Profit	0		853,768
Income (Loss) from Discontinued Operations	0		-747,580
Gain (Loss) on Disposal of Discontinued Operations	0		5,837,607
Provision (Benefit) for Income Taxes (Note 21)	0		19,800
Gain on Sale of Discontinued Operations	0		5,817,807
Net Income (Loss) from Discontinued Operations	0		5,070,227
Basic Income (Loss) per Share	$0		$1.43
Diluted Income (Loss) per Share	$0		$1.43
Weighted-average Shares Outstanding Basic (Note 6)	5,988,595		3,536,865
Weighted-average Shares Outstanding Diluted (Note 6)	5,988,595		3,651,100
Research and Development Expense	'		'
Operating Expenses:	0		295,138
Selling and Marketing Expense	'		'
Operating Expenses:	0		200,378
General and Administrative Expense	'		'
Operating Expenses:	0		0
Depreciation and Amortization	'		'
Operating Expenses:	0		0
Amortization Senior Debt Discount	'		'
Interest Expense on Senior Debt*	0	[1]	752,248	[1]
Interest Expense On Senior Debt	'		'
Interest Expense on Senior Debt*	0	[1]	353,584	[1]
Sales Of Products	'		'
Total Sales	0		1,768,754
Sales Of Engineering Services	'		'
Total Sales	$0		$358,921
[1]	Amounts reported represent the interest expense and the amortization of the discount on the Senior Term debt that was required to be repaid from the proceeds of the TDG Asset sale.

Discontinued_Operations_Additi

Discontinued Operations (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Discontinued Operations and Disposal Groups [Line Items]	'	'
Gain on Disposal of Discontinued Operations (Note 5), net of tax	$0	($5,817,807)

Gain_on_Asset_Disposal_Major_C

Gain on Asset Disposal (Major Components Of Gain On Sale Of Assets) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Significant Acquisitions and Disposals [Line Items]	'	'
Net Sales Price	$8,345,793	'
Professional Fees on Sale of Assets	-825,596	'
Federal Income Tax	-19,800	'
Sales Taxes on Asset Sale	-14,000	'
Net Gain on Sale of Asset	0	5,817,807
Which was paid at closing	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Net Sales Price	8,345,793	'
Accounts Receivable	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Book value of assets sold	-299,599	'
Inventory	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Book value of assets sold	-1,135,042	'
Tooling & Equipment	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Book value of assets sold	-120,832	'
Patents and Trademarks	'	'
Significant Acquisitions and Disposals [Line Items]	'	'
Book value of assets sold	($113,117)	'

Gain_on_Asset_Disposal_Additio

Gain on Asset Disposal (Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Gain On Asset Disposal Additional Information [Line Items]	'
Net Sales Price	$8,345,793
Additional Purchase Price Paid	$2,500,000

Net_Earnings_Loss_Per_Share_EP2

Net Earnings (Loss) Per Share (EPS) (Schedule Of Earnings Per Share Basic And Diluted) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012
Disclosure Earnings Per Share [Line Items]	'		'
Net (Loss) from Continuing Operations (A)	($10,146,228)		($4,747,387)
Net Income (Loss) (B)	-10,146,228		322,840
Add - Interest savings from converted debt	0		114,537
Adjusted Diluted Net Income (Loss) (F)	-10,146,228		437,377
Weighted Average Shares Outstanding:	'		'
Weighted average basic shares outstanding (C)	5,988,595		3,536,865
Dilutive effect of options and warrants	2,984,199		31,354
Dilutive effect of convertible debt	$0		$82,881
Weighted Average Dilutive Shares Outstanding (D)	5,988,595		3,651,100
Earnings (Loss) Per Share From Continuing Operations	'		'
Basic (A/C)	($1.69)		($1.34)
Diluted (1) (2)	($1.69)	[1],[2]	($1.34)	[1],[2]
Earnings (Loss) per Share	'		'
Basic (B/C)	($1.69)		$0.09
Diluted (F/D) (1)	($1.69)	[1]	$0.09	[1]
[1]	Due to net loss for period, dilutive loss per share is the same as basic.
[2]	Due to the antidilutive impact of the convertible debt under the if-converted method, the diluted earnings per share is the same as basic.

Accounts_Receivable_Net_Schedu

Accounts Receivable, Net (Schedule Of Account Receivable) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'
Accounts Receivable	$214,920	$170,600
Less: Allowance for Doubtful Accounts	0	0
Net	$214,920	$170,600

Inventories_Net_Components_of_

Inventories, Net (Components of Inventories) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Inventory Disclosure [Line Items]	'	'
Purchased Parts and Components	$1,094,250	$945,550
Work in Process	153,065	46,259
Finished Goods	280,279	259,112
Less: Reserve for Obsolescence	-573,967	-563,740
Net	$953,627	$687,181

Deferred_Offering_Costs_Schedu

Deferred Offering Costs (Schedule Of Deferred Offering Costs) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred Offering Costs [Line Items]	'	'
Professional and agentsb fees paid	$0	$57,500
Professional and agentsb fees included Accrued Expenses	0	142,071
Total	$0	$199,571

Tooling_and_Equipment_Net_Sche

Tooling and Equipment, Net (Schedule Of Tooling And Equipment) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment, Gross	$3,142,668	$3,063,707
Less: Accumulated Depreciation	-2,696,339	-2,398,740
Net	446,329	664,967
Tooling and Manufacturing Equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment, Gross	1,748,006	1,685,006
Computers and Software	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment, Gross	645,429	615,567
Funiture and Equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant and Equipment, Gross	$749,233	$763,134

Tooling_and_Equipment_Net_Addi

Tooling and Equipment, Net (Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'
Depreciation and Amortization	$377,840	$468,817

Patents_and_Trademarks_Net_Sch

Patents and Trademarks, Net (Schedule Of Patents and Trademarks) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]	'	'
Patents and Trademarks	$777,593	$803,687
Less: Accumulated Amortization	-281,985	-252,380
Net	$495,608	$551,307

Patents_and_Trademarks_Net_Add

Patents and Trademarks, Net (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]	'	'
Amortization	$54,979	$59,396
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	50,058	'
Impairment of Patents and Trademarks	73,423	64,703
Abandoned Patents and Trademarks	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Impairment of Patents and Trademarks	73,423	64,703
Amortization of Intangible Assets	98,798	171,868
Asset Impairment Cost	$25,375	$107,165

Software_Development_Costs_Sch

Software Development Costs (Schedule Of Software Development Costs) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Software Development Costs	$240,561	$0
Less: Accumulated Amortization	0	0
Net	$240,561	$0

Software_Development_Cost_Addi

Software Development Cost (Additional Information) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Amortization	$54,979	$59,396
Minimum [Member]	'	'
Finite-Lived Intangible Assets, Remaining Amortization Period	'3 years	'

Lines_of_Credit_Additional_Inf

Lines of Credit (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Line of Credit Facility [Line Items]	'	'
Lines of Credit (Note 13)	$0	$112,500
Line of Credit Facility, Interest Rate Description	'banks prime rate plus 1%	'
Line of Credit Facility, Amount Outstanding	$0	$112,500

Notes_Payable_Notes_Payable_Re

Notes Payable (Notes Payable Represent Promissory Notes) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Notes and Promissory Notes [Line Items]	'	'
Notes Payable (Note 14)	$278,467	$258,209
Officer and Shareholder	'	'
Notes and Promissory Notes [Line Items]	'	'
Notes Payable (Note 14)	229,787	165,738
President and Ceo | Secured By Asset [Member]	'	'
Notes and Promissory Notes [Line Items]	'	'
Notes Payable (Note 14)	37,383	46,737
Officer	'	'
Notes and Promissory Notes [Line Items]	'	'
Notes Payable (Note 14)	$11,297	$45,734

Notes_Payable_Notes_Payable_Re1

Notes Payable (Notes Payable Represent Promissory Notes) (Parenthetical) (Detail) (USD $)	Jul. 15, 2013	Mar. 21, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
			Officer and Shareholder	President and Ceo	Officer
				Secured By Asset
Notes and Promissory Notes [Line Items]	'	'	'	'	'
Interest percentage	16.00%	16.00%	18.50%	31.00%	7.49%
Debt Instrument, Frequency of Periodic Payment	'	'	'	'12 blended monthly payments	'
Debt Instrument, Periodic Payment, Principal	'	'	'	$5,645	$2,691

Customer_Deposits_Additional_I

Customer Deposits (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	$39,700	$0

Accrued_Expenses_Components_of

Accrued Expenses (Components of Accrued Expenses) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Accrued Liabilities [Line Items]	'	'
Accrued Wages and Related Costs	$91,385	$31,197
Accrued Compensation	360,670	181,322
Accrued Professional Services	69,500	181,227
Accrued Warranty Obligations	31,619	93,788
Other Accrued Expenses	1,090	32,138
Total	$554,264	$519,672

Accrued_Expenses_Changes_in_Ac

Accrued Expenses (Changes in Accrued Warranty Obligations) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Class Of Warrant Or Right [Line Items]	'	'
Accrued Warranty Obligations	$93,788	$118,611
Reductions for Settling Warranties	-74,287	-126,308
Warranties Issued During Period	12,118	101,485
Accrued Warranty Obligations	$31,619	$93,788

Derivative_Liability_and_Fair_2

Derivative Liability and Fair Value Measurements (Schedule of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Detail) (USD $)	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Assets	$0
Total assets measured at fair value	0
Derivative Liability	12,035,816
Total liabilities measured at fair value (Long-Term)	12,035,816
Fair Value, Inputs, Level 1	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Assets	0
Total assets measured at fair value	0
Derivative Liability	0
Total liabilities measured at fair value (Long-Term)	0
Fair Value, Inputs, Level 2	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Assets	0
Total assets measured at fair value	0
Derivative Liability	0
Total liabilities measured at fair value (Long-Term)	0
Fair Value, Inputs, Level 3	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Assets	0
Total assets measured at fair value	0
Derivative Liability	12,035,816
Total liabilities measured at fair value (Long-Term)	$12,035,816

Derivative_Liability_and_Fair_3

Derivative Liability and Fair Value Measurements (Schedule of Fair Value Level 3 Warrant Liabilities) (Detail) (Warrant Liabilities, USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Warrant Liabilities	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Fair value -beginning of period	$0	$0
Warrants issued	9,067,283	0
Reclassification of warrant liabilities to Additional Paid-in Capital	-526,245	0
Reclassification of warrant exercises to Additional Paid-in Capital	-80,500	0
Change in fair value	3,575,278	0
Fair value - end of period	$12,035,816	$0

Derivative_Liability_and_Fair_4

Derivative Liability and Fair Value Measurements (Compute The Fair Value Of Warrants Issued) (Detail) (USD $)	12 Months Ended			1 Months Ended	12 Months Ended	1 Months Ended	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 21, 2013	Mar. 21, 2013	Dec. 31, 2013	Mar. 21, 2013	Dec. 31, 2013
				Minimum [Member]	Minimum [Member]	Maximum [Member]	Maximum [Member]
Assumptions for Pricing Model:	'	'	'	'	'	'	'
Risk-free interest rate	2.81%	0.00%	'	0.77%	'	1.41%	'
Expected term in years	'10 years	'0 years	'	'4 years 7 months 13 days	'4 years 2 months 12 days	'5 years	'4 years 7 months 6 days
Volatility range for years 1 to 5	128.80%	0.00%	'	61.00%	'	110.00%	'
Value of warrants issued:	'	'	'	'	'	'	'
Fair value of warrants	$12,035,816	'	$9,067,283	'	'	'	'

Derivative_Liability_and_Fair_5

Derivative Liability and Fair Value Measurement (Additional Information) (Detail) (USD $)	0 Months Ended		1 Months Ended	12 Months Ended				0 Months Ended
	Aug. 05, 2013	Jul. 15, 2013	Mar. 21, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013	Sep. 21, 2013	Dec. 31, 2013	Aug. 05, 2013
							Additional Warrants [Member]	Public Equity Offering [Member]	Public Equity Offering [Member]	Public Equity Offering [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'	'	'	'	'	'	'	'
Embedded Derivative, Fair Value of Embedded Derivative Liability	'	$200,000	$800,000	'	'	'	'	'	'	'
Debt Conversion, Converted Instrument, Warrants or Options Issued	6,004,288	38,168	186,480	'	'	'	'	'	'	'
Derivative Liability	'	'	9,067,283	12,035,816	'	'	526,245	'	'	'
Derivative, Loss on Derivative	'	'	'	$3,575,278	$0	'	'	'	'	'
Derivative Liability For The Warrants To Purchase	4,025,000	'	'	'	'	'	'	'	'	127,717
Exercise Price Adjustment Feature Expired Warrants	'	'	'	'	'	'	'	102,357	'	'
Derivative Liability For The Warrants To Purchase Outstanding	'	'	'	7,147,775	656,641	867,628	'	'	25,360	'

Accrued_Compensation_Component

Accrued Compensation (Components Of Accrued Compensation) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Accrued Compensation	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Opening Balance	$1,010,096	$810,096
Additions	116,667	200,000
Subtractions	-1,126,763	0
Ending Balance	0	1,010,096
Accrued Interest	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Opening Balance	442,638	339,323
Additions	73,168	103,315
Subtractions	-515,806	0
Ending Balance	$0	$442,638

Accrued_Compensation_Additiona

Accrued Compensation (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]	'
Percentage Of Interest On Accrued Compensation	8.00%
Debt Instrument, Convertible, Conversion Price	$2

LongTerm_Debt_Components_of_Lo

Long-Term Debt (Components of Long-Term Debt) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'
Long term debt	$269,816	$2,775,441
Long Term Debt Current	99,320	1,060,188
Amount Due After One Year	170,496	1,715,253
The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal	'	'
Debt Instrument [Line Items]	'	'
Long term debt	-71,701	-97,003
Notes Payable | The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2012 over 48 months.	'	'
Debt Instrument [Line Items]	'	'
Long term debt	256,727	396,004
Notes Payable | The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013	'	'
Debt Instrument [Line Items]	'	'
Long term debt	84,790	101,748
Convertible, Senior Secured Term Debt	'	'
Debt Instrument [Line Items]	'	'
Long term debt	0	619,122
Long-term secured deferred trade payable | The principal and interest is subject to a fixed blended repayment schedule of 24 and 36 months, commencing July 15, 2013.	'	'
Debt Instrument [Line Items]	'	'
Long term debt	0	1,320,643
Officer [Member] | Notes Payable | The principal is not subject to a fixed repayment schedule	'	'
Debt Instrument [Line Items]	'	'
Long term debt	0	209,208
Officer [Member] | Notes Payable | The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013.	'	'
Debt Instrument [Line Items]	'	'
Long term debt	$0	$225,719

LongTerm_Debt_Components_of_Lo1

Long-Term Debt (Components of Long-Term Debt) (Parenthetical) (Detail)

Jul. 15, 2013

Mar. 21, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Notes Payable

Notes Payable

Notes Payable

Notes Payable

Notes Payable

Notes Payable

Notes Payable

Notes Payable

Convertible, Senior Secured Term Debt

Convertible, Senior Secured Term Debt

Long-term secured deferred trade payable

Long-term secured deferred trade payable

Long-term secured deferred trade payable

Long-term secured deferred trade payable

Long-term secured deferred trade payable

Long-term secured deferred trade payable

Officer [Member]

Officer [Member]

Officer [Member]

Officer [Member]

Minimum

Maximum

The principal is not subject to a fixed repayment schedule

The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013.

The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2012 over 48 months.

The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2012 over 48 months.

The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013

The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013

Minimum

Minimum

Maximum

Maximum

The principal and interest is subject to a fixed blended repayment schedule of 24 and 36 months, commencing July 15, 2013.

The principal and interest is subject to a fixed blended repayment schedule of 24 and 36 months, commencing July 15, 2013.

Notes Payable

Notes Payable

Notes Payable

Notes Payable

The principal is not subject to a fixed repayment schedule

The principal is not subject to a fixed repayment schedule

The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013.

The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013.

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long term debt, fixed interest repayment term

'

'

'24

'36

'

'36 months

'48 months

'48 months

'36 months

'

'15 months

'15 months

'24 months

'24 months

'36 months

'36 months

'

'

'

'

'36 months

'36 months

Long term debt repayment starting date

'

'

'

'

'

'

31-Oct-12

31-Oct-12

15-Jul-13

15-Jul-13

15-Oct-12

15-Oct-12

'

'

'

'

15-Jul-13

15-Jul-13

'

'

15-Jul-13

15-Jul-13

Long term debt, fixed interest rate

16.00%

16.00%

'

'

8.00%

'

'

'

12.00%

12.00%

13.50%

13.50%

'

'

'

'

12.00%

12.00%

8.00%

8.00%

12.00%

12.00%

LongTerm_Debt_Aggregate_Maturi

Long-Term Debt (Aggregate Maturities For All Long Term Borrowings) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'
2014	$99,320	'
2015	100,064	'
2016	70,432	'
2017	0	'
Thereafter	0	'
Long-term Debt Total	$269,816	$2,775,441

LongTerm_Debt_Additional_Infor

Long-Term Debt (Additional Information) (Detail) (USD $)

0 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

12 Months Ended

Aug. 05, 2013

Jul. 15, 2013

Mar. 21, 2013

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2012

Dec. 31, 2013

Dec. 31, 2013

Mar. 27, 2013

Dec. 31, 2013

Jul. 15, 2013

Mar. 21, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Jul. 15, 2013

Mar. 21, 2013

Jul. 15, 2013

Mar. 21, 2013

Jul. 15, 2013

Mar. 21, 2013

Jul. 15, 2013

Mar. 21, 2013

Jul. 15, 2013

Mar. 21, 2013

Jul. 15, 2013

Mar. 21, 2013

Jul. 15, 2013

Mar. 21, 2013

Jul. 15, 2013

Mar. 21, 2013

Dec. 31, 2013

Dec. 31, 2013

Securities Purchase Agreement [Member]

IPO [Member]

Convertible Debt [Member]

Maximum

Convertible, Senior Secured Term Debt

Convertible, Senior Secured Term Debt

Convertible, Senior Secured Term Debt

Convertible, Senior Secured Term Debt

Notes Payable

Notes Payable

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Hillair [Member]

Gentry [Member]

Minimum

Maximum

February 1,2014 Securities Purchase Agreement

February 1,2014 Securities Purchase Agreement

August 1,2015 Securities Purchase Agreement [Member]

August 1,2015 Securities Purchase Agreement [Member]

May 1,2014 Securities Purchase Agreement

May 1,2014 Securities Purchase Agreement

August 1,2014 Securities Purchase Agreement [Member]

August 1,2014 Securities Purchase Agreement [Member]

August 1,2017 Securities Purchase Agreement [Member]

August 1,2017 Securities Purchase Agreement [Member]

August 1,2016 Securities Purchase Agreement [Member]

August 1,2016 Securities Purchase Agreement [Member]

March 21, 2018 Securities Purchase Agreement [Member]

March 21, 2018 Securities Purchase Agreement [Member]

Securities Purchase Agreement [Member]

Securities Purchase Agreement [Member]

Securities Purchase Agreement [Member]

Line of Credit Facility [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayment of Convertible, Senior Secured Term Debt Loan

'

'

'

$2,137,983

$4,474,879

'

'

'

'

'

'

'

$4,450,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Senior Secured debt

'

'

'

269,816

2,775,441

'

'

'

2,374,682

'

'

'

0

619,122

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Senior Secured debt repayment term

'

'

'

'

'

'

'

'

'

'

'

'

'15 months

'15 months

'24

'36

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible, Senior Secured interest rate

'

16.00%

16.00%

'

'

'

'

'

'

'

'

'

13.50%

13.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Warrants Issued

'

'

'

'

'

'

'

'

'

533,333

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise price of warrants

'

'

'

'

'

'

'

'

'

$7.47

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of warrants

'

'

'

'

'

'

'

'

'

1,010,379

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unamortized discount

'

'

'

'

'

636,678

685,965

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Conversion, Converted Instrument, Amount

'

'

'

1,642,569

0

'

'

1,755,570

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Secured Long-term Debt, Noncurrent

'

'

'

'

'

'

'

'

'

'

200,000

800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200,000

800,000

'

'

Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

16.00%

16.00%

'

'

Debt Instrument, Periodic Payment

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50,000

200,000

12,500

50,000

50,000

200,000

50,000

200,000

12,500

50,000

12,500

50,000

12,500

50,000

'

'

'

'

Debt Instrument, Convertible, Conversion Price

'

'

'

$2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$5.24

$4.29

'

'

Debt Conversion, Converted Instrument, Warrants or Options Issued

6,004,288

38,168

186,480

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

186,480

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights

2.25

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.72

2.25

'

Debt Instrument Repayment Penalty

'

'

'

'

'

'

'

'

'

'

40,000

160,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40,000

160,000

'

'

Financial Advisor Fees

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50,000

Conversion of Stock, Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20,000

Investment Warrants Exercise Price

'

'

'

$2.75

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$4.72

Investment Owned, at Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

66,603

Debt Issuance Cost

'

'

'

257,691

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Investment Warrants Expiration term

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'5 years

'

'

Extinguishment of Debt, Gain (Loss), Net of Tax

'

'

'

-1,272,296

0

'

-1,272,296

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unamortized Debt Issuance Expense

'

'

'

'

'

'

$240,637

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Capital_Lease_Obligations_Equi

Capital Lease Obligations (Equipment Held Under Capital Lease Obligations Due) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Capital Leased Assets [Line Items]	'	'
Total Principal Payments	$41,552	$97,285
Less: Amount Due Within One Year	24,670	57,244
Amount Due After One Year	$16,882	$40,041

Capital_Lease_Obligations_Annu

Capital Lease Obligations (Annual Requirements For Retirement Of The Capital Lease Obligations) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Capital Leases Future Minimum Payments [Line Items]	'	'
2014	$31,687	'
2015	18,445	'
Total Minimum Lease Payments	50,132	'
Less: Amount Representing Interest	-8,580	'
Present Value of Minimum Lease Payments	$41,552	$97,285

Capital_Lease_Obligations_Summ

Capital Lease Obligations (Summary Of Assets Held Under Capital Leases) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'
Capital Leased Assets, Gross	$65,775	$189,371
Less: Accumulated Depreciation	-52,275	-81,190
Net	13,500	108,181
Funiture and Equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Capital Leased Assets, Gross	35,083	92,446
Computer and Software	'	'
Property, Plant and Equipment [Line Items]	'	'
Capital Leased Assets, Gross	$30,692	$96,925

Capital_Lease_Obligations_Addi

Capital Lease Obligations (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Capital Lease Obligations Additional Information [Line Items]	'	'
Depreciation	$377,840	$468,817
Assets Held under Capital Leases [Member]	'	'
Capital Lease Obligations Additional Information [Line Items]	'	'
Depreciation	17,247	34,433
Maximum [Member]	'	'
Capital Lease Obligations Additional Information [Line Items]	'	'
Capital Lease Obligation Monthly Lease Payments	2,049	'
Capital Lease Obligation Interest Rate	26.71%	'
Minimum [Member]	'	'
Capital Lease Obligations Additional Information [Line Items]	'	'
Capital Lease Obligation Monthly Lease Payments	$1,419	'
Capital Lease Obligation Interest Rate	25.15%	'

Income_Taxes_PreTax_Earnings_D

Income Taxes (Pre-Tax Earnings) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Pre Tax Earnings [Line Items]	'	'
Total Pre-Tax (Loss) Earnings	($10,146,228)	$382,838

Income_Taxes_Provision_Benefit

Income Taxes (Provision Benefit For Income Taxes) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Current Income Tax Provision (Benefit)	'	'
Federal - (all related to Gain on Sale of Discontinued Operations)	$0	$19,800
State and Foreign	0	0
State Tax Credit Refund	0	0
Net Change in Liability for Unrecognized Tax Benefits	0	0
Current Income Tax Expense (Benefit)	0	19,800
Deferred Provision (Benefit)	0	0
Total Provision (Benefit)	$0	$0

Income_Taxes_Reconciliation_Of

Income Taxes (Reconciliation Of Effective Rate) (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Effective Income Tax Rate Reconciliation [Line Items]	'	'
Federal Income Tax at Statutory Rate	34.40%	34.00%
State Tax Provision, Net of Federal Benefit	0.50%	3.50%
Foreign Income Taxed at Other Than 34%	-0.20%	0.00%
Meals and Entertainment	0.00%	1.40%
Stock Compensation Expense	-0.60%	16.10%
Research and Development Credits	-0.20%	4.20%
Loss on Derivative Valuation	-12.20%	0.00%
Debt Discount	-0.20%	0.00%
Officerbs Life Insurance	0.00%	0.30%
Change in Rate Assumptions	41.00%	-114.50%
Adjustments to Prior Year Tax Credits	0.70%	-11.60%
Effective Tax Rate	63.20%	-66.60%
Change in Valuations Allowance	-63.20%	77.70%
Net Effective Tax Rate	0.00%	11.10%

Income_Taxes_Components_Of_Def

Income Taxes (Components Of Deferred Tax assets And liabilities) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred Tax Assets and Liability [Line Items]	'	'
Inventory and Inventory Related Items	$196,871	$234,000
Warranty Reserves	10,845	32,000
Accrued Interest	9,673	152,000
Accrued Services	-1,887	28,000
Accrued Loss Contingency	0	9,000
Accrued Officer Compensation	111,276	0
Net Operating Loss Carryforwards	9,739,496	2,881,000
Accrued Compensation	0	405,000
Amortization	-143,364	0
(Gain)Loss on Fixed Assets	100,464	0
Patents Costs and Loss on Abandonment or Sale of Patents	-81,093	0
Charitable Contributions	2,487	0
Unrealized Gains/Losses	47,049	0
Tax Credit Carryforwards	1,466,429	1,399,000
Depreciation	7,832	11,000
Total Gross Deferred Tax	11,466,078	5,151,000
Valuation Allowance-100%	-11,466,078	-5,151,000
Net Deferred Tax	$0	$0

Income_Taxes_Additional_Inform

Income Taxes (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Taxes Additional Information [Line Items]	'	'
Unrecognized tax benefits	$11,405,522	'
Federal and State Net Operating Loss Carryforwards	28,395,033	'
Income Taxes Paid, Net, Total	$32,533	$19,012

Preferred_Stock_Additional_Inf

Preferred Stock (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Preferred Stock Shares Additional Information [Line Items]	'	'
Preferred Stock Shares Authorized	5,000,000	5,000,000
Preferred Stock Shares Issued	0	0
Dividends, Preferred Stock	$0	$0
Preferred Stock Shares Outstanding	0	0

Stock_Warrants_Changes_in_Warr

Stock Warrants (Changes in Warrants) (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Class Of Warrant Or Right [Line Items]	'	'
Warrants Outstanding, Beginning of Year	656,641	867,628
Exercised During the Year	-59,300	0
Issued During the Year	6,551,654	0
Forfeited During the Year	-1,220	-210,987
Warrants Outstanding, End of Year	7,147,775	656,641

Stock_Warrants_Additional_Info

Stock Warrants (Additional Information) (Detail) (USD $)	12 Months Ended		0 Months Ended		12 Months Ended	0 Months Ended		12 Months Ended	0 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Aug. 05, 2013	Aug. 05, 2013	Dec. 31, 2013	Aug. 05, 2013	Aug. 05, 2013	Dec. 31, 2013	Aug. 05, 2013	Aug. 05, 2013
			Warrants 1	Warrants 2	Minimum	Minimum	Minimum	Maximum	Maximum	Maximum
						Warrants 1	Warrants 2		Warrants 1	Warrants 2
Class of Warrant or Right [Line Items]	'	'	'	'	'	'	'	'	'	'
Outstanding Warrants Expiration Date	'	'	'	'	31-Dec-14	'	'	5-Aug-18	'	'
Weighted average term of warrants	'4 years 2 months 12 days	'	'	'	'	'	'	'	'	'
Weighted average exercise price of warrants per share	$2.75	'	'	'	'	$2.25	$2.25	'	$4.72	$5.24
Warrants Exercisable Share	'	'	$206,420	$38,168	'	'	'	'	'	'
Class Of Warrant Or Right Grants In Period	6,551,654	0	'	'	'	'	'	'	'	'
Warrants Issued Aggregate Fair Value	$9,067,283	'	'	'	'	'	'	'	'	'

Stock_Option_Plans_Summary_Of_

Stock Option Plans (Summary Of Stock Option Plans) (Detail)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Option Plan [Line Items]	'	'	'
Outstanding as of December 31, 2013	214,518	192,729	267,856
Available for future issuance under plan	342,420	'	'
Totals authorized by plan	556,938	'	'
2007 Plan	'	'	'
Stock Option Plan [Line Items]	'	'	'
Outstanding as of December 31, 2013	79,009	'	'
Available for future issuance under plan	0	'	'
Totals authorized by plan	79,009	'	'
2009 Plan	'	'	'
Stock Option Plan [Line Items]	'	'	'
Outstanding as of December 31, 2013	135,509	'	'
Available for future issuance under plan	342,420	'	'
Totals authorized by plan	477,929	'	'

Recovered_Sheet1

Stock Option Plans (Summary of Stock Option Activity) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Number of shares outstanding	'	'
Beginning Balance	192,729	267,856
Granted	45,000	0
Exercised	0	0
Expired or Forfeited	-23,211	-75,127
Ending Balance	214,518	192,729
Weighted Average Exercise Price	'	'
Beginning Balance	$10.68	$8.87
Granted	$2	$0
Exercised	$0	$0
Expired/Forfeited	$2.71	$0.65
Ending Balance	$9.72	$10.68
Exercised Price Range	'	'
Beginning Balance, lower limit	'	$0.46
Beginning Balance, upper limit	'	$17.50
Granted	$2	$0
Exercised	$0	$0
Expired or Forfeited, lower limit	$1.94	$0.46
Expired or Forfeited, upper limit	$17.50	$2.17
Ending Balance, lower limit	$1.71	$1.71
Ending Balance, upper limit	$17.50	$17.50

Stock_Option_Plans_Summary_Sto

Stock Option Plans (Summary Stock Option Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Summary Stock Option Information [Line Items]	'	'	'
Total Options Outstanding, Shares	214,518	192,729	267,856
Total Options Outstanding Weighted average remaining life (yrs)	'6 years 1 month 6 days	'	'
Total Options Outstanding, Weighted average exercise price	$9.72	$10.68	$8.87
Exercisable Options Outstanding Shares	200,387	'	'
Exercisable Options Outstanding Weighted average remaining life (yrs)	'5 years 7 months 6 days	'	'
Exercisable Options Outstanding, Weighted average exercise price	$9.71	'	'
Unvested Options Outstanding, Shares	14,131	'	'
Unvested Options Outstanding Weighted average remaining life (yrs)	'6 years 7 months 6 days	'	'
Unvested Options Outstanding, Weighted average exercise price	$9.91	'	'
Range of exercise price $1.71 to $2.00	'	'	'
Summary Stock Option Information [Line Items]	'	'	'
Exercise Price Range, Lower Range Limit	$1.70	'	'
Exercise Price Range, Upper Range Limit	$2	'	'
Total Options Outstanding, Shares	57,723	'	'
Total Options Outstanding Weighted average remaining life (yrs)	'7 years 7 months 6 days	'	'
Total Options Outstanding, Weighted average exercise price	$1.94	'	'
Exercisable Options Outstanding Shares	57,723	'	'
Exercisable Options Outstanding Weighted average remaining life (yrs)	'7 years 7 months 6 days	'	'
Exercisable Options Outstanding, Weighted average exercise price	$1.93	'	'
Unvested Options Outstanding, Shares	0	'	'
Unvested Options Outstanding Weighted average remaining life (yrs)	'0 years	'	'
Unvested Options Outstanding, Weighted average exercise price	$0	'	'
Range of exercise price $7.50 to $11.25	'	'	'
Summary Stock Option Information [Line Items]	'	'	'
Exercise Price Range, Lower Range Limit	$7.50	'	'
Exercise Price Range, Upper Range Limit	$11.25	'	'
Total Options Outstanding, Shares	102,637	'	'
Total Options Outstanding Weighted average remaining life (yrs)	'6 years 7 months 6 days	'	'
Total Options Outstanding, Weighted average exercise price	$10.67	'	'
Exercisable Options Outstanding Shares	88,506	'	'
Exercisable Options Outstanding Weighted average remaining life (yrs)	'5 years 7 months 6 days	'	'
Exercisable Options Outstanding, Weighted average exercise price	$10.78	'	'
Unvested Options Outstanding, Shares	14,131	'	'
Unvested Options Outstanding Weighted average remaining life (yrs)	'6 years 7 months 6 days	'	'
Unvested Options Outstanding, Weighted average exercise price	$9.91	'	'
Range of exercise price $15.00 to $17.50	'	'	'
Summary Stock Option Information [Line Items]	'	'	'
Exercise Price Range, Lower Range Limit	$15	'	'
Exercise Price Range, Upper Range Limit	$17.50	'	'
Total Options Outstanding, Shares	54,158	'	'
Total Options Outstanding Weighted average remaining life (yrs)	'3 years 7 months 6 days	'	'
Total Options Outstanding, Weighted average exercise price	$16.23	'	'
Exercisable Options Outstanding Shares	54,158	'	'
Exercisable Options Outstanding Weighted average remaining life (yrs)	'3 years 7 months 6 days	'	'
Exercisable Options Outstanding, Weighted average exercise price	$16.22	'	'
Unvested Options Outstanding, Shares	0	'	'
Unvested Options Outstanding Weighted average remaining life (yrs)	'0 years	'	'
Unvested Options Outstanding, Weighted average exercise price	$0	'	'

Stock_Option_Plans_Outstanding

Stock Option Plans (Outstanding Stock Option on Result of Operation) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012
Stock-Based Compensation Expense:	'		'
Stock Options	($159,272)		($172,233)
Income Tax Benefit	0		0
Decrease in Earnings Per Share:	'		'
Basic	($1.69)		$0.09
Diluted	($1.69)	[1]	$0.09	[1]
Stock options	'		'
Stock-Based Compensation Expense:	'		'
Stock Options	159,272		172,233
Income Tax Benefit	0		0
Net Decrease in Net Income	$159,272		$172,233
Decrease in Earnings Per Share:	'		'
Basic	$0.03		$0.05
Diluted	$0.03		$0.05
[1]	Due to net loss for period, dilutive loss per share is the same as basic.

Stock_Option_Plans_Assumptions

Stock Option Plans (Assumptions Used To Compute The Fair Value Of Stock Options) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Assumptions Used To Compute Fair Value Of Stock Options [Line Items]	'	'
Expected term in years	'10 years	'0 years
Volatility	128.80%	0.00%
Risk-free interest rate	2.81%	0.00%
Value of options granted:	'	'
Number of options granted	45,000	0
Weighted average fair value/share	$2	'
Fair value of options granted	$81,884	'

Stock_Option_Plans_Additional_

Stock Option Plans (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]	'	'
Weighted average remaining contractual term on unvested options	'5 years 7 months 6 days	'
Exercisable Options Outstanding Shares	200,387	'
Weighted average exercise price per share	$9.71	'
Unvested Options Outstanding, Shares	14,131	'
Unvested Options Outstanding, Weighted average exercise price	$9.91	'
Unvested Options Outstanding Weighted average remaining life (yrs)	'6 years 7 months 6 days	'
Granted	$2	$0
Exercise of Stock Options	$0	$0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value	81,884	'
Unrecognized stock compensation expense	$89,217	'
Weighted average recognition period	'1 year 1 month 6 days	'
Employee Stock Option Plan	'	'
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]	'	'
Percentage Of Stock Option Vesting Period	20.00%	'
Non Employee Director	'	'
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]	'	'
Percentage Of Stock Option Vesting Period	50.00%	'

Commitments_Future_Minimum_Pay

Commitments (Future Minimum Payments Required Under Operating Lease) (Detail) (USD $)	Dec. 31, 2013
Future Minimum Payments Required Under Operating Lease [Line Items]	'
2014	$45,670
Total Minimum Lease Payments	$45,670

Commitments_Additional_Informa

Commitments (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Commitment Contingencies Disclosure [Line Items]	'	'
Lease Expiration Date	30-Sep-14	'
Sale Leaseback Transaction, Monthly Rental Payments	$4,200	'
Operating Leases, Rent Expense	$104,766	$176,830

Employee_Benefit_Plans_Additio

Employee Benefit Plans (Additional Information) (Detail)	12 Months Ended
	Dec. 31, 2013
Employee Benefit Plans [Line Items]	'
Percentage Of Employee Deferrals	100.00%

Concentrations_Additional_Info

Concentrations (Additional Information) (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Concentrations [Line Items]	'	'
Concentration Risk, Percentage	0.00%	10.00%
Percentage On Accounts Receivable	79.00%	0.00%
Minority Stockholder	'	'
Concentrations [Line Items]	'	'
Concentration Risk, Percentage	17.00%	11.00%

Related_Party_Transactions_Add

Related Party Transactions (Additional Information) (Detail) (USD $)	Aug. 05, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
		Officer [Member]	Officer [Member]	Accrued Compensation	Accrued Compensation	Accrued Interest	Accrued Interest	Minority Stockholder	Minority Stockholder
Related Party Transactions Additional Information [Line Items]	'	'	'	'	'	'	'	'	'
Revenue from Related Parties	'	'	'	'	'	'	'	$0	$550,498
Related Party Transaction, Purchases from Related Party	'	'	'	'	'	'	'	199,476	274,373
Noncontrolling Interest, Ownership Percentage by Parent	'	'	'	'	'	'	'	5.00%	5.00%
Due from Related Parties	'	'	'	'	'	'	'	0	0
Due to Related Parties	'	'	'	'	'	'	'	90,818	66,000
Deferred Trade Payables Non Current	'	'	'	'	'	'	'	'	361,910
Deferred Trade Payables Current	'	'	'	'	'	'	'	'	120,637
Interest Expense, Debt	'	32,507	32,507	'	'	'	'	'	'
Interest Payable	'	'	213,795	'	'	'	'	'	'
Accrued Employee Benefits	'	107,209	107,209	0	446,532	'	'	'	'
Common Stock Price Per Share	2	'	'	'	'	'	'	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	2.25	'	'	'	'	'	'	'	'
Decrease In Employee Related Liabilities Noncurrent	'	'	'	$1,126,763	$0	$515,806	$0	'	'